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GENERAL INTRODUCTION
The "biochemistry of progesterone (pregn-4-ene-
5:20-dione) has been reviewed by Lieberman and Teich
(1953) and by Fukushima and Rosenfeld (1954); more
recent reviews are those by Roberts and Szego (1955)
and Dorfman (1955a). For older reviews, Pearlman (1948
Marrian (1949), Bradbury, Brown and Gray (1950) and
Samuels and West (1952) may be consulted. Certain
aspects of some recent papers will be found here and
in the general discussion.
Of the 53-pregnane (pregnane) and 5ci-pregnane
(allopregnane) derivatives which have been isolated
from human pregnancy urines, only 5(3-pregnane-3a: 20a-
diol (pregnanediol), 3a-hydroxy-53-pregnan-20-one
(pregnenolone) (Dorfman, Ross and Shipley, 1948) and
5a-pregnane-3a:20a-diol (allopregnanediol) (Kyle and
Marrian, 1951) have been shown conclusively to be
progesterone metabolites.
Dobriner, Lieberman, Rhoads and Taylor (1948) ob¬
served that 3a-hydroxy-5a-pregnan-20-one (allopregnan-
olone) was excreted in the urine of a normal woman only
during pregnancy; before and after pregnancy, none was
excreted. Strong evidence that allopregnanolone is
also a metabolite of progesterone was presented by
Dobriner and Lieberman (1950) who injected progesterone
into a normal man and examined the urine. The former
-2-
steroid was found only as a result of the admin¬
istration of progesterone; "before and after this
administration period, none was present. These
results have "been confirmed "by Davis and Plots (1956)
who observed excretion of allppregnanolone in the
urine of pregnant women; none was found in the urine
of the same women when not pregnant. Furthermore,
Plotz and Davis (1S56) found increased urinary
excretion of this steroid by pregnant women when they
were treated with progesterone. This leaves little
doubt that allppregnanolone is a metabolite of
exogenous progesterone; of course this is not complete
proof that it is produced normally from progesterone,
in vivo.
Pregnanediol only accounts for about 20^ of the
administered progesterone, while pregnanolone accounts
for about 3% and allopregnanediol and allppregnanolone
for even less.
In vivo metabolism of progesterone
Considerable evidence is available that the liver
is the major site of inactivation of progesterone;
Selye (1941) found that the anaesthetic and toxic
effects were very much greater in partially hepat-
ectomized rats than in normal rats. Kochakian,
Haskins and Bruce (1944) implanted progesterone pellets
in the muscle, subcutaneously, in a fold of the
mesentery (progesterone absorbed here would be
-3-
transported to the liver) and in the kidney of female
rabbits* Three rag* of progesterone were absorbed
from the pellet implanted in the muscle and this led
to a strongly positive endometrial response; twenty
mg. of progesterone v/ere absorbed from the pellet
implanted in the mesentery, but no endometrial
response was observed* In support of this, Masson
and Hoffman (1945) found that the dose of progesterone
required to induce endometrial proliferation in
rabbits was eight times as high in normal animals as
that required in partially hepatectomized animals.
The importance of the liver has been confirmed by
studies with progesterone-21-Ct4. Riegel, Hartop
and Kittinger (1950) found that after intraperitoneal
injection into rodents, the greatest amounts of radio¬
activity were in the liver; the concentration per
gram of tissue was highest in the pituitary and
adrenals, but these are small organs and the values
may not be very significant* Shen and Doisy (1953)
found that after intravenous injection into rats,
most of the radioactivity was found in the liver
and intestinal tract. In experiments with rats
with bile fistulas, Grady, Elliott, Doisy, Bocklage
and Doisy (1952) found, after intramuscular injection,
56-8#o of the activity in the bile; in similar
experiments but using intragastric administration,
Shen, Elliott, Doioy and Doisy (1954) reported
57-65/S of the activity in the bile; Doisy, Bocklage,
Shen and Valcourt (1952) reported 56-9activity in
the "bile of rats with bile fistulas.
However, other organs have been shown to be
involved, both in vivo and in vitro; Wiest, Berliner
and Woods (1954) injected progesterone-4-C14r intra¬
venously into totally eviscerated male rats and found
that after one hour no evidence of progesterone could
be found in any of the tissues, including blood.
Marker, Wittle and Lawson (195?) found that the
bull excretes pregnanediol in the urine but Marker
(1939) found that the steer does not. Thus the
testes must enter into the metabolism of progesterone
in some way.
In vitro metabolism of progesterone
Some of these in vivo observations have been
confirmed by in vitro studies, but as is generally
found in attempting to correlate in vivo and in vitro
work, some differences have arisen also. These
correlations and differences will be dealt with in
the general discussion.
That the placenta plays some part was shown by
Hagopian, Pincus, Carlo and Romanoff (1956) who per¬
fused progesterone-4-C14, in bovine blood, through a
near-term human placenta and obtained 6-ketoprogest-
erone; Berliner and Salhanick (1956) incubated the
same substrate with near-term human placenta and
obtained 6p-hydroxyprogesterone.
Hayano, Lindberg, Wiener, Rosenkrantz and Dorfman
(1954) found that the 20-ketone group of progesterone
was reduced to a 2Op-hydroxy group by incubation with
a beef corpus luteum homogenate.
The adrenal gland has a complicated role in the
metabolism (and biosynthesis) of progesterone and
other steroids; Levy, Jeanlos, Jacobsen, Hechter,
Schenker and Pincus (1954) showed that isolated bovine
adrenal glands will hydroxylate perfused progesterone
in the lip, 17a and 21 positions; Levy and Kushinsky
(1955) using the same technique achieved 19-hydroxyl-
ation of progesterone# Heard, Jacobs, O'Doimell,
Peron, Saffran, Solomon, Thompson, Willoughby and
Yates(l954) incubated progesterone with rat adrenal
glands and identified cortisone(l7c,21-dihydroxy-
pregn-4-ene-3:ll;20-trione) as one of the products.
Thus the adrenal gland effects hydroxylation and
oxidation, leaving untouched the double bond and
ketonic groups.
Lynn (1956) obtained an enzyme from rat and
bovine testicular extracts which split off the side-
chain of progesterone; 17a~hy&roxyprogesterone was
isolated as a probable intermediate. This work has
been substantiated by Slaunwhlte and Samuels (1956)
who incubated rat testis tissue with progesterone
-6-
and obtained 17a-hydroxyproges terone, androst-4-ene-
5:17-dione and testosterone(l76-hydroxy-androst-4-en-3-one)L
Rongone, Bocklage, Strength and Doisy (1956)
found that blood itself metabolizes progesterone,
since bovine blood albumin yielded 5£5-pregnane-3:20-
dione (pregnanedione) after incubation with progest¬
erone. This appears to be confirmation of the work by
Hooker and Forbes (1949) who observed that plasma stored
at body temperature rapidly lost its initial progest¬
ational activity; it is possible, though, that some of
this activity is not due to progesterone since chemical
studies (Haskins, 1950; Hinsberg, Pelzer and Seuken,
1956) have shorn lower progesterone levels in blood
than those indicated by bio-assay (Hooker et al.,
1949).
Many studies have been made of the effect on
progesterone of liver and liver cell fractions of
various species; these will be dealt with in the
general discussion.
Thus it can be seen that progesterone is subjected
to attack by many tissues, both in the male and the
female, and these tissues, either singly or together,
perform reduction, oxidation, hydroxylation and
degradation.
Taylor (1953) investigated the in vitro metab¬
olism of progesterone with rat liver homogenate and
isolated metabolic products. The problem set before
the present author was to separate the homogenate
into nuclear, mitochondrial, microsomal and soluble
fractions and to find the fraction or fractions
responsible for the reduction of Ring A# While this
work was proceeding, Tornkins and Isselbacher (1954)
published their results and so further investigations
in this field were, for the time being, abandoned#
At this point, as a result of publications in
the clinical field, Dr Grant became interested in the
role of glycyrrhetinic acid (GA) in steroid metabolism,
believing it to be an inhibitor of steroid inactivation.
The author investigated this in vitro and found GA to
be a powerful inhibitor of Ring A reduction#
Subsequently, Professor Marrian desired an
investigation into the metabolic products of progest¬
erone in the rat in vivo and so rat excreta were






To prepare homogenates, Taylor (1953) used 6-12
months old female rats of the Wistar strain* Since
the present in vitro work was an extension of Taylor's
investigations, it was decided to continue using rats
of the same age, sex and strain* The animals were
killed "by dislocation of cervical vertebrae, the livers
removed raj>idly and placed in an ice-cold medium, the
same as that in which the homogenisation was to he
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The liver tissue was removed from the medium,
placed on filter paper and weighed into ice-cold medium
in the glass mortar of the homogenizer which had been
inserted previously into an outer vessel packed with
crushed ice and water* A nylon pestle was used; this
had the advantage over a glass one in that wear of the
pestle and of the mortar was very greatly reduced and
thus the clearance between the shearing surfaces
remained uniform for many months# In addition,
Brendler (1951) showed that the resulting homogenates
were more uniform and contained fewer intact cells
than those prepared in all-glass homogenizers* The
tissue was ground for one minute, with ten passages
of the pestle* The homogenate was diluted to the
-9-
appropriate volume v/ith more ice-cold medium and
pipetted immediately into the incubation flasks, unless
it was to he used for fractionation studies# In
general, a 1C$ homogenate was prepared, that is, x g#
of moist liver were diluted, after homogenization to
lOx ml# For certain experiments, some of this was
used as homogenate and the remainder separated into
cell fractions#
2) Cell fractions
Fractionation procedures were based on the method
of Schneider and Hogehoom (i960) for homogenates
prepared in 0#25M-sucrose. Gentrifugation was carried
out using the superspeed unit with four place angle
head for the M#S#E# Major refrigerator centrifuge, with
a bowl temperature of 0°#
Nuclei and unbroken cells were sedimented at
700g for ten minutes# The supernatant fraction
(supernatant) was removed carefully and the mito¬
chondrial fraction obtained by centrifuging twice at
5,00Gg for ten minutes. On removing the supernatant
fluids (supernatants) from these sediments, as far
as possible the loosely packed *fluffy layer* was
allowed to remain behind since Laird, Nijgaard, His
and Barton (1953) have shown that this layer is mito¬
chondrial rather than microsomal in nature#
The combined supernatants were centrifuged at
25,000£ for one hour in order to obtain a microsomal
-10-
pellet, Schneider et al.(i960) used 57,000^ for one
hour to sediment microsomes, and the former procedure
only yields part of the microsomal fraction. This
was, however, the maximum centrifugal force which
could he obtained with the centrifuge available. On
a few occasions it was possible to obtain the use of
a Spinco Model E ultraeentrifuge. With the aid of
the preparative rotor A, a complete yield of microsomes
was obtained by centrifuging at 150,000g for one hour
and the resulting supernatant was microsome-free.
When a nuclear, mitochondrial or microsomal
fraction was to be used in an investigation, it was
washed by re-suspending in the ice-cold homogenizing
medium and again centrifuging. The fraction was
then suspended in ice-cold medium by means of a glass
ball pestle, which fitted the centrifuge tube closely,
and the suspension was diluted with more medium to
the same volume as the original homogenate; in this
v/ay the activity of various cell fractions could be
compared with each other and with the original
homogenate. Similarly, the final supernatant was
also diluted to the original homogenate volume,
C) Dialysis
When supernatants from rat liver homogenates
required to be dialysed, they were placed in a sac
of Visking tubing and dialysed in the cold room at
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0-1°, usually against one litre of solution, the
solute varying with the experiment, A magnetic
stirrer was used and fresh solution was provided
after a few hours,
D) Incubation Media
All solutions used in ensymic experiments were
prepared in distilled water from an all-glass still
and all reagents were of Analytical Reagent (A,R,)
grade, where available.
In most experiments, 25 ml, conical flasks were
used as incubation vesselsj in some of the later
experiments, QuickfIt & Quartz test tubes, 150 mm,
long with B19 sockets were used. The reaction
mixture varied but unless otherwise stated was as
follows:- 0, 05M-KC10. OOBM-MgSQj. ; 0, Oil-potassium
phosphate, pH 7.4$ 0,0005M-adenosine triphosphate
(ATP) sodium salt, pH 7,4, and 0,002M-sodium citrate,
pH 7,4, One ml, of enzyme preparation was used and
the final volume was normally 3 ml,, but for some
experiments was 2 ml. As far as possible other
substances added were adjusted to pH 7.4 and potassium
salts were used when applicable,
E) Measurement of pH
Measurements were at first made on a battery-
operated pH meter (Type D-417, Muirhead & Co., Ltd.)
but in later experiments a Pye universal pH meter and
millivoltmeter (Cat. No, 11066) was used.
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F) Addition of Steroids
Propylene glycol (propane-1:2-diol) has a high
solvent power for steroids and has come to "be used
increasingly as a vehicle, since steroids can be
added in very small volumes (Taylor, 1954; Brownie
and Grant, 1954). Progesterone and ll-deoxycortico-
sterone (21-hydroxy-pregn-4-ene~3:20-dione) were added
to incubation mixtures as solutions in propylene glycol
containing about 0.5 mg. in, respectively, 0*050 ml.
and 0.040 ml.; these were measured from an Agla
f
micrometer syringe (Burroughs, Wellcome & Co.).
Duplicate 0.010 ml. volumes of these solutions
were measured into test tubes, dissolved in 10 ml.
ethanol and the solutions analysed for steroid content
in the spectrophotometer. In this way, the amount
of steroid added to incubation flasks could be
calculated from a calibration curve. Propylene
glycol from an Agla micrometer syringe was added to
all vessels, whether containing steroids or not, in
such amounts that the final volume of propylene glycol
was the same in all vessels.
G) The General Arrangement of Incubation Experiments
Most experiments included Incubation, 'control'
and blank vessels, in duplicate, and except where




Into these vessels was placed the particular
reaction mixture desired. It was found "by experiment
that homogenate, stored at 0° , lost appreciable activity
in one hour* whereas cell fractions were relatively
stable. Thus for incubations in which homogenate was
to be used, either alone or in conjunction with cell
fractions, the homogenate was added to the vessels as
soon as prepared, steroid added and incubations begun
at once. In some experiments, comparison was made
more complete by including incubations both with fresh
homogenate and with homogenate stored in the cold room
during the fractionation.
In experiments involving cell fractions these, as
prepared, were stored in the cold room until the final
fraction was ready when all enzyme preparations and
steroids were added to the incubation vessels.
Incubations were carried out on a Warburg bath at 37°
with shaking at a frequency of about 100/minute, in
general for one hour, in air.
2) Blanks
These were carried out in the same way as
incubations except that, instead of steroid solution,
solvent only was added to vessels. The resulting
apparent steroid content was consistently low.
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5) Steroid recovery controls ^Controls*)
These were carried out in the same way as
incubations, except that the steroid solutions were
added after incubation; extraction procedures were
begun immediately and in this way a check was made on
the steroid recovery levels#
H) Steroids
I) Progesterone (Organon) was recrystallized twice
from n-hexane and once from aqueous ethanol to give
prisms (a-progesterone) melting at 127#5-128°.
2) 11-deoxycorticosterone (DOC) was prepared from 11-
deoxycorticosterone acetate (Organon); the product
melted at 138-142°.
3) 5j3-pregnane-5a: 20a-diol was a pure substance
melting at 235#5-236°.
4) Sodium 5|3-pregnane-3as 20a-diol 3-glucuronidate
(NaPG), from human pregnancy urine, melted with
decomposition at 269-270°.
5) 5p-pregnane-3a:20a-diol diacetate, kindly provided
by Dr A. Klopper, Clinical Endocrinology Research
Unit, Edinburgh, had melting points of 165-166°
and 180-181°.
6) 5a-pregnane-3a:20a-diol diacetate, was gifted by
Dr A. Klopper and had a melting point of 141-142®
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(Hartraann and Locher, 1935, reported 141*5-142,5°).
Fifty mg* of this were refluxed for 30 minutes with
5 ml* of a 5% solution of KOH in methanol, and the
mixture poured into 50 ml* of cold water* This was
extracted with ether, the ether extract v/ashed with
water, dried with NaaSQ*, filtered and evaporated
to give 33 fflg* of crude allppregnanediol* By
recrystallisation from the minimum amount of boiling
methanol, 16 mg* of crystals, which melted sharply
at 247-247*5°, were obtained (Hartmann et al*,1935,
reported 248-248*5°) and this material was used for
recovery experiments from rat urine and from rat
liver homogenates*
7) 5a-pregnane-3:20-dione melted at 196-200° and was
kindly supplied by Dr W# Taylor, University of
Durham*
8) 50-pregnane-3:20-dione, 3a-liydroxy-5a-pregnan-20-one
and coprostan-3P-ol were supplied by the Medical
Research Coimcil Steroid Reference Collection and
had melting points of 120-121°, 168-172° and 101-
103°, respectively*
I) Adenosine Triphosphate (ATP)
This was a commercial preparation of the sodium
salt (Light & Co., Ltd*), containing at least 40^
adenosine diphosphate .
-16-
J) Diphosphopyridine Nucleotide (DPN)
• '
This was prepared from yeast by the method of Le
Page (1949a) and purified by counter-current distrib-
ution (Hogeboom and Barry, 1948), It was obtained also
as a by-product of the preparation of triphosphopyridine
nucleotide (TEN) from sheep liver, the DPN being eluted
from the ion-exchange resin column before the TEN#
The material obtained was not less than 45/2 pure as
assayed speetrophotometrically following reduction by
fresh sodium dithionite (Le Page, 1949b), Occasion¬
ally, DPN bought from C.P, Boeliringer & Soelme GMBH,
Mannheim, and reputed to be 100$ pure was used# DPN
was stored in a stoppered tube at -20°#
Reduced diphosphopyridine nucleotide (DPNH) was
either bought from the same company as the yeHoy/
sodium salt, 64$ pure, or prepared as a solution only,
by reducing DPN with sodium dithionite (Hogeboom and
Schneider, 1950)#
K) Triphosphopyridine Nucleotide (TPN)
This was prepared from fresh sheep liver by a
modification of the method of Le Page and Mueller (1949/
and purified by gradient elution from an ion-exchange
resin column of Dowex-l-formate# The material obtained
was not less than 43$ pure as assayed by the method of
Horecker and Romberg (194(3) using isocitric dehydrogen¬
ase prepared according to Straub (1942)# Isocitrate
for this assay was prepared from dimethyl-D-isocitric
-17-
lactone. TPN was stored in an evacuated tube at -20° •
Reduced triphosphopyridine nucleotide (TPNH) v/as
prepared as a solution only, by reducing TEN with sodium
dithionite by the same method as that used for the prep¬
aration of DPHH (Hogeboom et al•, 1950)•
l) Melting Points
Melting points were determined on a modified hot-
stage apparatus of the Kofler type (Klyne and Rankeillor,
1947)* and are uncorrected.
MlDetermination of Progesterone and DOC in Liver
Preparations ~
1) Introduction
Progesterone present in liver preparations v/as
determined by the method of Taylor (1954) and ?/here
applicable, modifications of the extraction procedure
introduced by Brownie (1955) were used; DOC was deter¬
mined by the method of Brownie (1955).
2) Protein precipitation
Fifteen ml. cold acetone were added to each 25 ml.
incubation flash to terminate the reaction and precip¬
itate protein. In experiments involving homogenate,
it was necessary to chill the flasks to -20° before
filtration and to use hot acetone for further extraction.
When cell fractions were used, the reduced phospholipid
content made it possible to omit the chilling of the
vessels, and hot extraction was found to be unnecessary;
-18-
three extractions with 10 ml, volumes of acetone at
room temperature were sufficient.
Latterly, with cell fractions, it was found that
steroid recoveries were not lowered if the addition of
acetone was omitted and the extracting solvent mixture
(see 3) below) was added directly to the incubation
mixture. For this purpose, incubations were carried
out in Quiclefit & Quarts test tubes 5 at the end of the
incubation the extracting solvents were added, the
tubes stoppered and shaken vigorously,
5) Extraction of aqueous phase
For progesterone, n-hexane:chloroform (9:1, v/v)
was used; for DOC, benzene:chloroform (6:1, v/v). The
test tubes in which these extractions were carried out
were always centrifuged routinely irrespective of the
degree of arnulsification, before the organic phase was
drawn off,
4) Purification of steroid extract
Celite was purified, partition columns prepared,
chromatography carried out and steroids determined as
described by Taylor (1S54) and Brownie (1955),
5) Accuracy of the method
Recovery of progesterone from rat liver homog-
enates was of the same order as that found by Taylor
(1954); recovery from rat liver fractions, in experiments
-19-
in which the use of acetone was omitted, gave recoveries
ranging from 94-99^1, Recovery of DOC from rat liver
homogenates was of the same order*
Results
a) Recovery of Progesterone from rat liver homogenates







h) Recovery of progesterone from rat liver fractions
(.use of acetone omitted) "
Progesterone added Progesterone recovered




















c) Recovery of DOC from rat liver homogenates







These results show that as far as cell fractions
are concerned, the precipitation of proteins with
acetone nay "be omitted without deleterious effect on
the recovery of progesterone.
6) Specificity of the method
As far as progesterone is concerned, this has
"been discussed by Taylor (1953) j however, since the
submission of Taylor's thesis, Hayano et al»(1254), as
mentioned in the introduction to this thesis, have
isolated 20p-hydroxy-pregn-4-en-3-one after incubating
progesterone with beef corpus luteum homogenate.
Furthermore, Caspl, Lindberg, Hayano, Cohen, Matsuba,
Rosenkrantz and Dorfman (1956) showed that liver tissue
may reduce the 20-keto group of a pregnene derivative
to a 20-hydrcxyl without affecting Ring A when they
incubated DOC with hog liver homogenate and isolated
20a:21-dihydroxy-pregn-4~en-3-one« Thus it is
possible that rat liver may yield a 20-hydroxy-pregn-
4-en-S-one as a metabolite of progesterone> even if
this is so, the former steroid does not appear to
contaminate the progesterone fraction since the author
„0"1
has obtained occasionally complete destruction of
progesterone as measured by absorption at 240 mg,; if
a 20-hydroxy-pregn-4-en-3-one had been a metabolic
product in these experiments, and had been eluted with
the progesterone fraction, it would have yielded sig¬
nificant absorption at 240 rng. That this contamination
is unlikely is confirmed by the results of Hayano et al.
(1954) who found that 20p-hydroxy-pregn-4~en-3-one was
eluted from a silica gel column after the complete
elution of progesterone*
With regard to DOC, Schneider (1952) isolated four
metabolites after the incubation of DOC with rat liver
slices, but none of these, even if possessing similar
partition coefficients to DOC, retain the S-keto-4-ene
group and therefore would not absorb significantly at
240 mp.
Possible contaminants of the DOC fraction are the
20:21-dihydroxy-pregn-4-en-3-ones and as noted above
when discussing the specificity of the method for
progesterone, 20a:21-dihydroxy-pregn-4-en-3-one was
isolated by Caspi et al. (1S56) after incubation of
DOC with hog liver homogenate. These authors found
that its running rate on paper in a toluene-propylene
glycol system was only about one sixth that of DOC.
Thus it is probable that the retention volume of the
former on a Celite column using the DOC solvent system
(Brownie et al•, 1954) would be sufficiently greater than
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that of DOC to prevent contamination of the latter.
It is therefore concluded that the method is probably
specific for the determination of DOC after incubation
with rat liver preparations#
7) Ultraviolet spectroscopy
For this purpose# a Unicam Photoelectric Quarts
Spectrophotometer# S.P. 500 (Unicam Instruments#
Cambridge# Ltd*) was used, A slit width of C#Q0 ran#
v/as employed as this gave optimum sensitivity;
otherwise# the technique described by Taylor (1955)
was complied with*
SECTION I
THE DESTRUCTION OP PROGESTERONE BY RAT LIVER
PREPARATIONS
A) Introduction
In this introduction an attempt will "be made to
present a concise summary of some salient features
concerning the role of the main cell fractions and
their interdependence in cell metabolism* It is
realized that this account will suffer from the defects
common to all summaries hut, for a fuller account,
which cannot be given here, the reader is referred to
Buxrnotrdm (1952). For a discussion of the technique
of differential centrifugation and the significance of
the localization of enzymes, De Duve and Berthet (1954)
may be consulted.
The living cell is a highly complex structure, the
nucleus and cytoplasm of which have complicated inter¬
relationships. Experiments with enucleated Amoeba
(Lorch and Danielli, 1950) have shown that, for a period,
the cell appears to carry on all its activities as
before. Sooner or later, however, metabolism dwindles
and the cell dies. Comandon and de Fonbrunne (1939)
found that A, sphaeronucleus which had been enucleated
for three days, completely recovered when another
nucleus was transplanted into it. This was not the
case, however, if the new nucleus was exposed to any
medium other than cytoplasm; that is, the transfer had
to be made through apposed cell surfaces. This implies
strongly that isolated nuclei Eire never normal. If a
medium can be found which will preserve nuclei so that
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they can restore enucleated cells, then it will "be the
medium of choice for isolating nuclei.
Comandon et al.(1939) found that if a nucleus was
restored to an Amoeba which had been enucleated for six
days, then only partial recovery took place. Seemingly
some alteration had taken place in the cytoplasm which
the nucleus could not then restore, showing that the
nucleus is not independent of the cytoplasm.
Confirmation of this is shown by the fact that
energy yielding processes, for example, the glycolytic
system and the Krebs cycle, are absent in nuclei; they
depend on the cytoplasm for their energy supply.
Conversely, the nucleus provides the cytoplasm with DPN
for various enzynic reactions which occur there (Hoge-
boom and Schneider, 1952a). This DPN-synthesizing
enzyme is one of the few which has been shown definitely
to reside in the nucleus.
The nucleus has also been shown to be active in
synthesizing ribose nucleic acid and it is known that
this passes into the cytoplasm (Goldstein and Plaut,
1955) where it associates with the mitochondria and
microsomes (Jeener and Szafarz, 1950); as a possible
confirmation of this Duryee (1950) observed that
nucleoli, migrating from the chromosomes, apparently
may fuse with the nuclear membrane and evert their
contents into the cytoplasm. The main role of the
nucleus may be said to be a long-term dependence of
I eCUcia i sn.-\
~>
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cell function on nuclear contributions. For a review
of nuclear physiology, the reader is rederred to Mazia
(1952) and for a recent discussion of some nuclear
functions see Mazia (1956).
Many particles are found in the cytoplasm. The
mitochondria are the largest and contain many enzymes.
Not only is the Krebs cycle carried on here hut the
energy thus obtained is stored up in the form of phos¬
phate bonds as in ATP. The enzymes which produce ATP
are found to be in close liaison with those requiring
ATP for synthetic purposes (Green, 1954), Thus, oper¬
ation of the Krebs cycle leads to ATP production which
enables fatty acids, awaiting oxidation, to form an
active fatty acyl coenzyme A, which undergoes p-oxidation
and then outers the Krebs cycle. Thus, once initiated
by ATP, the process of fatty acid oxidation is self-
perpetuating, since the final stages of the cycle result
in the production of more ATP, This led Green (Green,
Loomis and Auerbach, 1948) to regard the enzymes in
mitochondria not as being a random conglomeration but
as an organized complex, which he called the cyclophorase
system. This concept is supported by the fact that
all enzymes required for the Krebs cycle are found in
the mitochondria and in such proportions that any mem¬
ber of the cycle can be oxidized completely without any
excess accumulation of intermediate products. Further,
the coenzymes required are found to be bound to their
n
o
apoenzyraes and some of the cyelophorase enzymes are
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found not to function if they are isolated from the
complex (Green, 1952), A useful discussion on the
biochemistry of mitochondria is that by Schneider (1953).
The other main particle fraction consists of the
microsomes. DEN-eytochrome c reductase is one of the
few enzymes which has been demonstrated to be present
(Hogeboom et al., 1950). Liver microsomes, with the
aid of the soluble fraction, detoxify, by various
methods, drugs and other substances foreign to the cell
(Brodie, Axelrod, Cooper, Gaudette, La Du, Mitoma and
Udenfriend, 1955). They are also at least partly
responsible for the reduction of steroids (Glenn, Siu
and Recknagel, 1956) and the synthesis of cholesterol
(Bucher and McGarrahan, 1955) and proteins (Little-
field, Keller, Gross and Zamecnih, 1955). Adrenal
microsomes, with TPNH and oxygen, can hydroxylate
steroids, including progesterone, in the 21 position
(Ryan and Engel, 1956). Microsomes are thought by
some to be disintegration products of mitochondria but
there is evidence that microsomes are formed in the
Golgi region (Zollinger, 1950) and that they may be
converted gradually into mitochondria.
In centrifugation studies, intermediate part¬
icles are found, forming the 'fluffy layer'.
Tracer techniques have shown that these are not
microsomes; they appear to be small mitochondria
(Laird et al.,1953). No clear cut classification of
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cytoplasmic pas tides can "be made at present; thus
mitochondria have "been shorn to consist of" at least
four types of particles (Paigen, 1954)•
The supernatant remaining after removal of
particles from the cytoplasm contains many proteins and
a correspondingly large number of enzymes. One of the
main groups is that responsible for anaerobic glycol¬
ysis $ most of the activity of liver homogenates as
measured by lactic acid production has been recovered
in the supernatant, but its activity was increased by
addition of particulate fractions (Le Page and Schneider
1948), This implies that the supernatant contains
most of the enzymes involved and the enhancement by
other fractions is a good example of the integrated
activity of cell structures. Oxidizing enzymes and
enzymes capable of reducing steroids are also found in
the supernatant, though their coenzymes must either be
added as such, or provided from other cell fractions.
To summarize, no cell fraction can be regarded as
autonomous5 all are dependent on one another for
survival and for effecting cell metabolism,
Taylor (1955) showed that progesterone is metab¬
olized both by rat liver slices and homogenate and
isolated metabolic products after incubation of prog¬
esterone with homogenate,
Dr Grant, of this Department, thought it would be
of great interest to fractionate rat liver homogenates
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and to find the cell fraction responsible for the
metabolism, of progesterone; this was, therefore, made
the prime aim; a complete fractionation study was not
attempted.
Homogenization was carried out in 0,25M-suerose
containing 0.12M-nicotinamide, thus giving a final
concentration of 0*04M-nicotinamide; in certain exper¬
iments, as indicated, 0.25M-sucrose was used, and
nicotinamide was added to the incubation medium to
provide a final concentration of 0. 04M-nicot inamide.
Further work in this section was stopped, for the
time being, when Tomkins et al, (1954) published their
findings with regard to the reduction of steroids by




A 25% homogenate was prepared and part of it was























(i) Metabolism of progesterone does not occur with the
nuclear fraction to any significant extent#
(ii) Metabolism takes place with the supernatant but to
a lesser degree than with the homogenate#
« All recoveries are corrected for the blank
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A 25% homogenate was prepared and 2 ml. were used
immediately for incubations; a few ml. were stored in
the cold room until all other enzyme preparations were
ready, and the remainder was divided into two equal
parts. These were "both separated into a nuclear
fraction and a 700g supernatant; the nuclei and super¬
natant from one tube were used as such, and the nuclear
fraction in the other tube was suspended back into its
own supernatant.
Results
After incubation Progesterone recovered
(tig.) {%)
Fresh homogenate 122 25
134 27
Homogenate stored at 0° 146 30
152 31
700g supernatant 196 40
206 42
Nuclear fraction 451 92
456 93
700£ supernatant 172 35





(i) Metabolism of progesterone does not occur with the
nuclear fraction.
(ii) The lower activity of 700£ supernatant as compared
with homogenate is not simply an ageing effect; this
loss in activity is only partially restored by the






After incubation Progesterone recovered
■» ■— »■!"■»i.>/H ■ '% i» .■■■■» - ■"■ '/yyV
Homogenate 300 54
311 56
Mitochondrial fraction 538 97
544 98








Mitochondrial fraction 480 94
488 94

























(i) The mitochondrial fraction does not metabolize
progesterone
(ii) Metabolism occurs with 5,0Q0g supernatant, but to
a lesser extent than with homogenate#
In the following experiment, after the homogenate
had been prepared, 2 ml# were used immediately for
incubations, a small portion was stored in the cold
room until all other enzyme preparations were ready,
and the remainder was separated into a nuclear fraction,
which was discarded, and a 700£ supernatant, a small
portion of which ¥/as stored in the cold room# The
remainder was divided into two halves and both were
centrifuged to yield a mitochondrial fraction and a
5,000£ supernatant# The mitochondrial fraction and
5,000g supernatant in one centrifuge tube were used as
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such; the mitochondrial fraction in the other tube was
suspended back into its own supernatant with the aid of
a ball pestle.
Results
After incubation Progesterone recovered
— -
(bg.) C8T
Presh homogenate 56 12
61 13
Eomogenate stored at 0° 195 42
205 44
70Qg supernatant 233 50
247 53
Mitochondrial fraction 436 94
445 96
5,000g supernatant 321 69
325 70
5,000g supernatant 288 62





(i) The lower activity of 700£ supernatant as compared
with homogenate is not simply an ageing effect.
(ii) 50G0& supernatant is less active than 70Q£
supernatant; this loss of activity is only partially
restored by the addition of the mitochondrial
fraction which, by itself, is inactive.
-34-
Nuclear and Mitochondrial fractions combined
The nuclear and mitochondrial fractions have "been
found to be inactive with regard to progesterone metab¬
olism. The following experiment was carried out to
determine if these two fractions had any activity when
combined. An homogenate was prepared, 2 ml. were used
immediately for incubations and a small portion was
stored in the cold room until all other enzyme prepar¬
ations were ready. The remainder was divided into
three equal amounts, these being centrifuged to yield
nuclear fractions and TOOg supernatants. The nuclear
fraction and 700g supernatant in one tube were used as
such. The 700£ supernatant from a second tube was
centrifuged to yield a mitochondrial fraction and a
5,0Q0£ supernatant; the undisturbed third tube was
recentrifuged at the same to give a 5,000£ residue





After incubation Progesterone recovered
Fresh homogenate











(i) The 5,000£ residue (nuclear + mitochondrial frac¬
tions) shows definite activity, though the nuclear
and mitochondrial fractions show little or none#
(ii) The 5,000£ supernatant prepared direct (thus
combining the nuclear and mitochondrial fractions)






















prepared in the usual manner# K C\a,a,..cse* \/ . ^4 ij*; Vj/ii.c.euuSt<
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2) Damaged mitochondria
A 25% homogenate was prepared and a portion of it
was separated into a mitochondrial fraction and a
5»000g supernatant. The mitochondrial pellet was
suspended in 0.25M-sucrose and divided into two equal
portions. Both portions were recentrifuged and the
resulting pellets were made up to the appropriate
volume with, respectively, 0.2514-sucrose and distilled
water. The former suspension was divided into three
equal volumes| one portion was used as such, a second
portion was placed in a deep freeze cabinet at -20° for
eight days, after which it was thawed out by immersion
in water at 37°, and the third portion was frozen and
thawed three times by placing alternately in a solid
C0S -acetone mixture and water at 37° •
Prom the same liver, another 2U% homogenate was
prepared, but 0.12M-nicotinamide was used as the homog¬




After incubation Progesterone recovered
—tug} m—
Homogenate prepared in 0 0
0.25M-sucrose# 0.32M- 0 0
nicotinamide




Mitochondrial fraction 474 94
474 94
Mitochondrial fraction 453 91
aged 8 days at -20° 464 92
Mitochondrial fraction 454 90
frozed and thawed 3 times 464 92
Mitochondrial fraction 4-54 90





(i) An homogenate prepared in the absence of sucrose
still retains high activity.
(ii) The damaged mitochondrial fractions appear to
show a little activity.
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D) Microsomal Fraction
A 25% homogenate was prepared and a microsomal
fraction obtained from it "by centrifugation at 25,000^
for 1 hr.
Results
After incubation Progesterone recovered
Cng.)
Microsomal fraction 463 85
463 85
Microsomal fraction 426 78
with 0. 001M-DFN 437 80
Microsomal fraction 366 67





(i) The microsomal fraction metabolizes progesterone.
(ii) The metabolism is increased by added DPN.
(iii) The metabolism is still further increased by DFNH.
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A 25% homogenate was prepared and from it a
5,000^ supernatant was obtained} the major portion
of this was separated into a microsomal fraction
and a 150,000g supernatant# DFNH (0#001M) was added
to the incubation flasks#
Results
After incubation Progesterone recovered
~
; (KT
5>000g supernatant 0 0
5 1
Microsomal fraction 127 26
152 31























In the presence of DPHH:
(i) The microsomal fraction metabolizes progesterone;
(ii) 150,000g supernatant does not metabolize progesterone;
(iii) 5,000g supernatant, that is, one containing
microsomes, metabolises progesterone to a greater
extent than the microsomal fraction alone.
Inhibition of the microsomal fraction
A 25/3 homogenate was prepared and a microsomal fraction
obtained from it; 0,00B1-DPHH was added to the incubation
flasks.
Results
After incubation Progesterone recovered
■ i—'-m urn, . ii, i, i ,• Lum wiini, h| Jwi» i.^ ii«y»„ ,i i i ,n. m
{&£•) (/•)
Microsomal fraction 132 27
145 30
Microsomal fraction with 446 92
0, OOlM-p-chloromercuri- 456 94
benzoate








In the presence of DPHH:
(i) The microsomal fraction metabolizes progesterone;
(ii) this metabolism is Inhibited by 0,OOlK-p-chloro-
mercuribenzoate; the inhibition is partially reversed
by 0, OOlM-reduced glutathione.
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BS) Supernatant Fraction
This will "be considered -under three headings,
namely 5,000$ supernatant, 25,000$ supernatant and
150,000$ supernatant.
l) 5,000% supernatant
As can be seen from sections C and D, supernatant
is less active than homogenate hut is more active than
the microsomal fraction.
a) Effect of storage at 0°
A 25/5 homogenate was prepared and from it a 5,000$
supernatant was ohtainedj this was divided into three
equal portions, one "being used immediately, the second
portion being used after it hr. storage and the third
portion after 1 hr, storage.
Results
After incubation Progesterone recoveredW/nvD Ova V/iiv 1 v vU V
USD(^7


















5,000$ supernatant, unlike homogenate, is stable
when stored at 0°.
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b) Enzyme lability
In the following experiment, a 5,000g supernatant
was divided into three equal portions\ one was stored
at 0° and the other two were centrifuged at 26,000g,
The supernatant from one tube was used as such and the
microsomal pellet in the oilier was stirred back into
its own supernatant#
Results
























(i) 5,0GOg supernatant is less active than homogenate
but more active than 25,0GQg supernatant.
(ii) Addition of the microsomal fraction to 25*G00g
supernatant only partly restores its activity to
that of the 5,Q00g supernatant.
—43—
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(i) Metabolism of progesterone by 5,000g supernatant
is increased by addition of 0.0G1M-DPN,















d) Effect of dialysis
A 25% homogenate was prepared and from it a 5»000£
supernatant was obtained# A few ml# were taken for
immediate incubation and the remainder was divided into
four equal portions; one portion was stored in the cold
room at 0-1° for 4 hr. A second portion was dialysed
for 2 hr# against 1 litre of a 0.12M solution of nicot¬
inamide in 1#15$> KC1 solution; the third and fourth
portions were dialysed against a similar solution for
4 hr# and 20 hr# respectively# The nicotinamide
solution was changed after 2 hr, and after 4 hr#
Results
After incubation Progesterone recovered
5»Q00jg, supernatant
After 2 hr# dialysis
After 4 hr# dialysis

















After 4 hr# dialysis,
0.001M-DPN added




(i) Enzyme activity diminishes as a result of dialysis#
(ii) This diminution in activity is not caused by loss
of nicotinamide or by ageing#




















e) Effect of replacing magnesium ions with manganous ions
The incubation mixture as given on p. 11 was used
except that 0. Q4M-2-amino~2-(hydroxy-methyl)-propane-
It 3-diol (Tris) buffer, pH 7,4 replaced phosphate
buffer in order to avoid precipitation of manganous
phosphate; 0.0G02M-DRTH v/as added and, in the second





Manganous ions provide a more effective co-factor
than do magnesium ions.
..b
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f) Comparison of citrate with Versene (ethylene diamine
tetra-acetic acid)
In order to test the chelating role ascribed to
citrate by Wiswell and Samuels (1953)* the effect of
Versene was tried.
Results
After incubation Progesterone recovered
(SgT)™07F
5,000g supernatant 421 81
437 84
5§000r supernatant 442 85
with O, 0G4M-Versene 442 85
5,Q00g supernatant 302 58





(i) Versene does not affect metabolism appreciably,
(ii) Citrate increases metabolism.
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2) 25 g00Op; Supernatant
Ab can be seen from p* 42 , 25,000g supernatant is
less active than 5,000g supernatant and if the micro¬
somal fraction is incorporated back into it, its
activity is only partially restored*
a) Effect of citrate and coenzymes
The incubation medium (p* 11) was present in the































































(i) 25,000g supernatant metabolises progesterone to
a small extent only,
(ii) This activity is increased greatly by TPNH,
especially in the presence of citrate,
(iii) Activity is also increased to a lesser extent
by DPN and DPNH.
b) Effect of increasing TPNH concentration
A 25#000£ supernatant was prepared and half was
stored in the cold room while the remainder was
dialysed against 1,16% KCl solution for 22 hr.
Incubation medium: 0,05M-KC1; 0,005M-MgS04J 0,01M-
potassium phosphate pH 7,4, 0.04M-nicotinamide,
Results
After incubation Progesterone recovered
■
us.) m
Stored SS^OOQg super- 356 62
natant with 0.0003M-TPNH 356 62
Dialysed 25#0G0g super- 489 85
natant with 0.0003M-TPNH 489 85
Dialysed 25,000g super- 425 74
natant with 0.0006M-TPNH 442 77
Dialysed 25f000g super- 391 68





The ability of this dialysed supernatant to
reduce TPN was measured in the spectrophotometer.
The cells contained the same mixture of substances
as in the incubation medium, together with 1 ml, of
dialysed supernatant.
Results






(i) Dialysis reduces the ability of 25»000g super¬
natant to metabolize progesterone,
(ii) Increasing the concentration of TPNH increases
metabolism by dialysed supernatant,
(iii) Dialysed supernatant is unable to reduce TENj
addition of isocltrate enables reduction to
proceed.
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c) Reduction of TEN and oxidation of TPNII by supernatant
It was shorn on p. 49 that dialysed supernatant
was unable to reduce TPN unless Isocitrate were added.
Since TomMns et al. (1954) had shown that TPNH was
required for the reduction of steroids, it seemed
possible that undialysed supernatant would be capable
of reducing TPN; further, that dialysed supernatant would
oxidize TPNH.
(i) Comparison of reduction of TPN by supernatant and
by dialysed supernatant'
An homogenate was prepared in 0.25M-sucrose and
a 25,0Q0g supernatant obtained from it. Half of this
was stored in the cold room, while the remainder was
dialysed against 1 1. of 1.15% KCl for 18 hr., fresh
solution being provided after 4 hr.
The following volumes (in ml.) of fluids were
pipetted into 1 cm. cells and these were placed in the
cell-holder of the Unicam 8.P. 500. The TPN was added
last, the cell contents mixed, the time noted and
optical densities at 340 mg determined at intervals.






•- • DIALYSED SUPERNATANT.
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The results are shorn in Pig. 1.
"5
t 1 ' . fl
Conclusion
The rate of reduction of TEN is very much lower w:
dialysed supernatant than with supernatant.
ith
liil Oxidation of TENH "by dialysed supernatant
An horaogenate was prepared in 0.25M-sucrose and
a 25,QG0g supernatant obtained from it. This was
dialysed against 1 1. of 0«D4M-Tris buffer for 22 hr.,
fresh solution being provided after 4 hr. Since it
was possible that aerobic oxidation of TENH might
occur, a control was included in which water replaced
the supernatant.
The following volumes (In*ml,) of fluids were
pipetted into 1 cm. cells and these were placed in
the thermostat cell-holder (Grant, 1955) equilibrated
FIGURE 2 . THE OXIDATION OFTPNH BY DIALYSED 25,000^ SUPERNATANT.
i i i i i i i I I I
I 2 345 67 89IO
TIME INMINUTES
• • TPNH PLUS DIALYSED SUPERNATANT.
• « TPNH PLUS WATER.
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at 37°• The TPNHwas added last, the cell contents
mixed, the time noted and optical densities at 340 mji
determined at intervals# This was carried out in two
stages, since the thermostat cell-holder accommodates
only two cells#


























The results are shown in Pig. 2.
Conclusions
(i) TPNH is stable at 37° in aqueous solution at pH 7.4,
in the presence of air.
(ii) Dialysed 25,0Q0g supernatant oxides TPNH rapidly





a) Effect of different incubation times
An homogenate was prepared, in sucrose and from it
a 25#0Q0£ supernatant was obtained; this was dialysed
against 1,15% KC1 solution for 22 hr. Citrate was
omitted and 0.001M-2?PNH was added to all flasks.
Results
After incubation Progesterone recovered
' 1 " nmmmmmm .■*- ■«'■■■. immm ■ n» m m ■■■ ■« —
QxgT) OD
Incubated 15 min. 419 88
428 90
Incubated 30 min. 357 77
366 79
Incubated 45 min. 297 64
321 69
Incubated 60 min. 256 55
274 59







Metabolism of progesterone is complete in about
60 min.
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a) Precipitation of enzyme with ammonium sulphate
A 25,000g supernatant was prepared, and a portion
of this stored in the cold room; to the remainder was
added sufficient solid ammonium sulphate (Analar) to
produce 50;o saturation; solution was effected by gentle
inversion of the tube and it was allowed to stand for 15
rain, in the cold room. The precipitate was centrifuged
off and solid ammonium sulphate was added to the super¬
natant to produce VQyo saturation; the above procedure
was repeated and the precipitate again centrifuged off.
This precipitate was dissolved in water and made up to
one tenth the volume of its own supernatant. A portion
of this solution was dialysed against 0.025M-potassium
phosphate buffer, pH 7.4-, for 2 hr. This dialysed
enzyme and the stored supernatant were then used for
incubations; 0.0003M-TPHH was added to the flasks.
Results
After incubation Progesterone recovered
——__ -nfer—-—m—
25,000g supernatant 257 46
260 48






(i) Some of the enzyme activity in 25,000g supernatant
responsible for the metabolism of progesterone is
precipitated between 50 and 7Q?a saturation with
ammonium sulphate.
(ii) Less than one tenth of the original activity of
th^> miwawno + on* woe
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f) Paper chromatography of metabolic products
Solvent system A (Bush, 1952) was used, except
that n-hexane replaced light petroleum. Thus the
mixture used was 200 ml, water, 800 ml. methanol and
1,000 ml, n-hexane. Chromatograms were run in glass
tanks, similar to those used "by Bush (1952), and
chromatography was carried out in a temperature
controlled room at about 20°. Sheets of Whatman
No. 1 filter paper were used to saturate the atmosphere
of the tank and Whatman No. 42 filter paper (46 cm.
long, 15 an. broad) was used for chromatogramsj the
general technique was that of Bush (1952), The dried
sheets were dipped into 2.5N-K0H in freshly distilled
ethanol, excess reagent removed by thorough blotting
and the sheets then sprayed with 2$ m-dinitrobensene
(purified after Callow, Callow and Emmens, 1938) in
ethanol; colours were developed by placing in an oven
at 65° (cf. Savard, 1953).
Single chromatograms of progesterone (10 jig.) and
5ct+pregnane-3:20-dione (allopregnanedione) (20 pg. ),
a mixed chromatogram of the two and a chromatogram of
allopregnanedione together with material from a blank
Incubation, were run for 5 hr. Progesterone could be
detected as a fluorescent spot by means of ultraviolet
light and gave the same Rp value in single and mixed
chromatogramsj allopregnanedione was detected after
spraying and drying, as a blue spot, and gave the some
-56-
Hp value in all three chromatograms.
The partially purified solutions of metabolites
remaining in the flasks after Incubations with 5,000g
and 25,000g supernatants had been carried out, were
evaporated to dryness, dissolved in C5.5 ml. ethanol,
and 0.01 ml. used for paper chromatography. A spot
was detected with precisely the same Rp value as that
given by authentic allo-pregnanedione. and giving the
same colour; this was obtained with both the 5,000g
and 25,000g supernatants.
Conclusions
(i) With this solvent system, progesterone has an Hp
value of 0.72 and 5a-pregnane-3:20-dione has an
Hp value of 0.89.
(ii) 5a-pregnane~3:20-dione has been identified
tentatively as a metabolite of progesterone after
incubation with bt000g and 25,G0Gg; supernatants.
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3) 150,OOOg supernatant
As can toe seen from p. 39 , 150,0G0g supernatant
was inactive in the presence of 0.001M-DPNH. On p*
it was shown that Mg++ and Mn++ effectea a marked
difference in metabolism; to investigate whether this
still held in the absence of citrate, cis-aconitate or
isocitrate, the following experiment was carried out#
An homogenate was prepared in 0#25M~sucrose and an
15Q»000g supernatant obtained from it; this was dialysed
against 1 1# of 0,04M~Tris buffer, pH 7#4, for 22 hr.,
fresh solution being provided after 4 hr# The incub¬
ation medium consisted of 0.04M~Tris buffer, pH 7#4,
and 0,04&-nicotinamide.
Results
After incubation Progesterone recovered
(ME.) (%>
No additions 465 92
475 94
With 0.0003M-TPNH 343 68
368 73
With 0.00Q3M—TPHH 353 70
and 0. 005M-MgS0* 358 71
With 0.0003M-TPNH 364 72






(i) Dialysed 150f000g supernatant is inactive in the
absence of added coenzyme.
(ii) It is active in the presence of 0#0003H-TFNH*
(iii) The absence or presence of Mg*+ or Mn++ with
dialysed 150„000£ supernatant in the presence of
0. Q003M-TFNH does not affect metabolism.
SECTION II
INHIBITION BY GLYCYRRHETINIC ACID AND OTHER SUBSTANCES
OF THE DESTRUCTION OF PROGESTERONE AND 11-DEOXYCQRTICO-
STERONE BY RAT LIVER PREPARATIONS
FIGURE .4.
.COOH





METHYL VINYL KETONE .
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A) Introduction
Glycyrrhizinic acid, which is responsible for the
sweet taste of liquorice, is the diglucopyruronide of
glycyrrhetinic acid (GA) (Lythgoe and Trippett, 1950)
which has a triterpenoid structure (Ruzicka, Jeger and
Ingold, 1945) as in Pig. 4 (Beaton and Spring, 1955).
Hydrogen atoms in 0 positions at ring junctions have
not been drawn in; it can be seen that as far as the
junctions of Rings A, B, C and D are concerned, the
stereochemistry is the same as in allppregaane.
Clinical interest in liquorice was first aroused
when Revers (1946, 1948, 1951) reported that it
relieved the pain of gastric ulcers, but if given in too
great a dose caused oedema; it has been shown since
that the former effect is due to the glycyrrhizinic
acid-free part of liquorice extract (Revers, 1956).
Molhuysen, Gerbrandy, Be Vries, De Jong, Lenstra,
Turner and Borst (1950) showed that liquorice and its
active principle, glycyrrhizinic acid, have a DOC-like
action in that they promote sodium and water retention
and potassium loss, in normal humans, but when tried
on one severe case of Addison's disease, did not have
these effects.
Groen, Pelser, Will©brands and Kamrainga (1951)
described two Addisonian patients who responded to
treatment with deoxycorticosterone acetate and who
could be maintained in correct electrolyte balance
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with liquorice or glycyrrhizinie acid alone, contrary
to the findings of Molhuysen et al>(1950).
Pelser, Willebrands, Prenkel, Van der Heide and
Groen (1953) showed that OA, when administered orally
to Addisonians, was more effective than its diglucuron-
ide, glycyrrhizinic acid. Pelser, f/illebrands and
Groen (1953) found that during i>rolonged treatment of
Addisonians with liquorice or GA, the maintenance dose
could he reduced after some time; in fact, if it were
not reduced, oedema set in. Groen, Pelser, Wille¬
brands, Veer and Van der Kerlc (1953) investigated the
effect of derivatives and analogues of GA on the
electrolyte balance of Addisonians# They concluded
that the heto group and/or the carboxyl group (either
as such, or as a ketol-acetate group) were essential
for activity.
Dr Grant suggested to the present author that the
effect of GA might be due to its inhibiting the metab¬
olism of DOC in vivo. It Y?as decided,therefore, to
investigate the action of GA on steroid metabolism
in vitro.
A recent review of the inhibition of enzymes
by drugs has been given by Quastel (1956).
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B) Materials and Methods
X) Materials
a) GA was a gift from Stafford Allen & Sons, Ltd#,
London; it had a melting point of 278-282°• As
it was found to "be insoluble in water but soluble
in propylene glycol, it was added to the incubation
vessels from an Agla micrometer syringe as a
solution in propylene glycol# An equivalent
quantity of this solvent was added to blank and
* control* vessels and to vessels containing smaller
quantities of GA, in such amounts that the final
volume of propylene glycol was the same in all
vessels#
b) 11-desoxoglyeyrrhetinic acid (DGA) was kindly
provided by Professor P#S# Spring, Royal Technical
College, Glasgow; it had a melting point of 320-
323°• As it was found to be insoluble in water
and not sufficiently soluble in propylene glycol,
it was added to incubation flasks as a solution
in ethanol#
c) Methyl vinyl ketone was the product of Light & Co#,
Ltd#, and was not purified further#
d) p-quinone was purified by sublimation and had a
melting point of 113-114°•
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e) Commercial acetophenone was purified by dist¬
illation, the fraction boiling at 198-199° being
collected.
f) Glucose-6-phosphate, barium salt, B.D.H, Labor¬
atory Eeagent, was converted to the soluble
sodium salt for enzyme experiments.
g) Glucose-6-phosphate dehydrogenase was the
commercial product of the Sigma Chemical Co.,
St. Louis, Missouri. For experimental use,
it was dissolved in fresh 0.1$ (w/v) NaHCOs
solution.
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2) Recovery of Steroids in Presence of GA
It was necessary to ascertain whether or not GA
was carried through the analytical procedure for
steroids and appeared in the same final fraction as
progesterone or DOC, particularly in view of the fact
that a solution of GA in ethanol gives a peak at 248 irp.
(van Katwijk and Huls in*t Veld, 1955). For this
purpose, duplicate blank incubations, duplicate
progesterone * control* incubations and single DOC
"control* incubations were carried out in the absence
and in the presence of 0.001M-GA .
Results






































Blank values and recoveries of progesterone and
DOC are unaffected by the presence of 0*001M-GA.
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C) The Inhibition by GA of the Metabolism of Progest¬
erone "by Rat Liver Homogenate














(i) GA Inhibits the metabolism of progesterone by rat
liver homogenate.
(ii) At these enzyme, coenzyme and substrate concen¬
















2) In the presence of added 0.0Q1M-DPHH
Results
After GA concn. Progesterone recovered
Incubation CM) Xm t (%)
Homogenate 55 11
70 14
H 0.0002 290 58
295 59
M 0.0005 395 79
420 84






(i) Inhibition occurs in the presence of added 0.001M-
DPNH.
(ii) Increasing the inhibitor concentration causes
increased inhibition.
D) The Inhibition "by GA of the Metabolism of DOC by
Rat Liver Homogenate




























(i) 11-deoxyeorticosterone is destroyed "by rat liver
homogenate in the presence of 0. 001M-DFHH.
(ii) GA inhibits this destruction and higher concen¬
trations cause increased inhibition.
(iii) Inhibition by GA of the reduction of Ring A is
possibly a general phenomenon for steroids with an
a$-unsaturated ke tonic group.
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E) The Inhibition "by GA of the Metabolism of Progest¬
erone by Rat Liver Supernatant"
A 25,000g supernatant was prepared in 0.25M-
sucrose and dialysed against 1.15A KC1 solution for
4 hr., the KC1 solution being changed after 2 hr.;
this procedure removes citrate, cis-aconitate and
isocitrate almost completelyj 0.©^-nicotinamide and
0,G003M-TPNH were added to all incubation vessels#
Citrate was omitted in all cases and 0.0001M-GA was
added to alternate incubations; 'controls* were
included for each of the four progesterone concen¬
trations#
Results
Progesterone % recovery of progesterone










(i) The metabolism of progesterone by 25,000g super¬
natant in the presence of TPKIi and in the absence
of added citrate is inhibited by 0. 0001M-GA.
(ii) Under these conditions, complete inhibition
occurs at all the substrate concentrations tested.
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F) The Inhibition by GA and Other Substances of the
Metabolism of Progesterone by Rat' Diver Homogenate"
The fact that GA contains an a{3-unsaturated ketone
group, in common with progesterone and DOC was suggest¬
ive' that this might be the active moiety of the inhib¬
itor. To investigate this possibility* the effect on
progesterone metabolism of various substances was tried.
Ethanolic solutions (0.1 ml.) of DGA, methyl vinyl
ketone, p-quinone and acetophenone were usedj the
acetone was added as an aqueous solution. The final
concentrations of these substances and of GA were
0.0005M. The effect of 0.1 ml. of ethanol alone was
investigated, and progesterone recovery Controls*
were carried out in the presence of 0.00G5M-TXJA,
methyl vinyl ketone and p-quinone.
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Results
After incubation Progesterone recovered
(lis.) en-
No additions 321 63
331 65
With GA 475 93
486 95
With acetone 347 68
352 69
With G#1 ml. ethanol 377 74
377 74
With acetophenone 383 75
387 76
With DGA 398 78
403 79
With methyl vinyl ketone 500 98
510 100
With p-quinone 505 99
510 100
'Controls*
No additions 480 94
With DGA 490 96
With methyl vinyl ketone 495 97
With p-quinone 486 95
Progesterone added 510
Conclusions
(i) Progesterone recovery is unaffected by the presence
of 0,0005M-DGA, methyl vinyl ketone or p-quinone,
(ii) Acetone causes a slight inhibition of metabolism,
(iii) Ethanol inhibits metabolism to some extent,
(iv) Acetophenone causes a further slight inhibition,
(v) DGA produces a small degree of inhibition,
(vi) Methyl vinyl ketone and p-quinone effect complete
inhibition.
FIGURE .5. TPN REDUCTION BY CONCURRENT OXIDATION OF GLUCOSE-6 - PHOSPHATE
IN THE ABSENCE AND IN THE PRESENCE OF GA.
O-S-i
O +■—* » ■ ■ • • ■
O I 23456789 10 20
TIME IN MINUTES.
• • GA ABSENT.
• • GA PRESENT.
FIGURE . 6. TPN REDUCTION BY CONCURRENT OXIDATION OF GLUCOSE - 6" PHOSPHATE
IN THE A8SENCE AND IN THE PRESENCE OF METHYL VINYL KETONE.
0-5
0-4-




• METHYL VINYL KETONE ABSENT.
• • METHYL VINYL KETONE PRESENT.
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G) The Effects of GA and Methyl Vinyl Ketone on the
Oxidation of Glucose-G-phosphat'e '
It was necessary to determine whether GA and methyl
vinyl ketone were general or specific enzyme inhibitors.
The concurrent reduction of ©PH, as glucose-6-phosphete
is oxidized by glucose-6-phosphate dehydrogenase, was
chosen as a means of measuring any inhibition of this
enzyme. The following volumes (in ml.) of solutions
were pipetted into 1 cm. cells and placed in the cell
'
carrier of the Unicam S.P. 500. The glucose-6-phos-
phate was added last, the cell contents mixed, the time
noted, and the optical densities at 340 mp. determined
at minute intervals for 10 min. and finally at 20 min.
Cell 1 Cell 2 Cell 3 Cell 4
(blank) (blank)
0. 0Q01M—TPN 1.0 1.0 1.0 1.0














0, 03M-GA — - 0.05 0.05
0.045M-gTucose-6-phosphate 0.4 • 0.4
3.0 3.0 3.0 3.0
In the case of methyl vinyl ketone, 0.1 ml. of a
0.015M solution of it replaced 0.05 ml. of GA solution
and the volume of water was adjusted accordingly.
The results are shown in Figures 5 and 6.
Conclusion
GA and methyl vinyl ketone both cause an initial
lag in the rate of reduction of TFN, but the final
values attained are the same.
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H) The Effects of Methyl Vinyl Ketone and p-quinone
on "the" 'l'lp-hydroaylat ion of dSC"
These experiments were carried out as a further
test of specificity for these inhibitors. The
following incubation medium was used: 0.00Q2M-TPNJ
0.1 ml, glucose-6-phosphate dehydrogenase; 0.006K-
glucose-6-phosphate; 0,04M-Tris buffer, jH 7,4. The
hydroxylating enzyme solution was prepared as described
by Grant and Brownie (1955) and 2 ml# were added to
each incubation vessel, the final volume being 5 ml* j
0,1 ml. of ethanolic solutions of methyl vinyl ketone






No additions 13 3
With 0,1 ml, ethanol 36 8
With methyl vinyl ketone 49 11







(i) Ethanol causes some Inhibition of lip-hydroxylation.
(ii) Methyl vinyl ketone increases this inhibition
slightly.
(iii) p-quinone causes marked inhibition.
SECTION III
THE METABOLISM OF PROGESTERONE IN THE SAT IN VIVO
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A) Introduction
Taylor (1954) isolated allopregnanedione and
allopregnanolone after incubation of progesterone with
female rat liver in vitro. In order to attempt to
correlate these results with in vivo metabolism, it
was decided to investigate rat urine and faeces for
the possible presence of progesterone metabolites
after intraperitoneal injection of progesterone. In
particular, use was made of a specific, sensitive and
accurate method for the determination of pregnanediol
in urine, devised by Klopper, Michie and Brown (1955),
and of a modification of this method for the determin¬
ation of allopregnanediol.
B) Materials and Methods
1) Materials
Materials used for pregnanediol determinations
were prepared by the methods given by Klopper et al,
(1955), Girardfs Reagent T and 2:4-dinitrophenylhydraz-
ine (B.D.H, Laboratory Reagents) were used without
further purification; glacial acetic acid (Analar) was
redistilled before use. Alumina, for chromatographic
analysis (Savory & Moore, Ltd,, London; 100/150 mesh),
was activated by heating at 100° in vacuo for 2 hr.;
its activity was tested by the method of Brockmann
and Schodaer (1941), Deactivated alumina was
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prepared by the method given by IQopper et al. (1955).
Six months old male rats of the Wistar strain were
used for most of the work in order to avoid, as far as
possible, endogenous progesterone metabolism.
2) Collection of urine and faeces
Twenty four rats were weighed individually and
divided evenly into 4 groups, so that each group
weighed 1665 g., the average weight of each rat being
278 g.
The 4 groups of 6 rats were placed in metabolism
cages which had wire mesh floors and stood over sine
funnels with perforated sine tops to collect the
faeces. The urine was collected in beakers containing
0.5 ml. toluene to act as preservative. In order to
avoid contamination of excreta with rat cake, a diet
was prepared from powdered rat cake, gelatin and water,
which gave a firm jelly (Wilson, 1954). It was given
to the rats ad lib. in screw capped jars, with circular
apertures 3.7 cm. diameter in the lids; drinking water
was also provided. The urine and faeces were coll-
*
ected daily and the latter stored for 3 days in an
evacuated desiccator over PsCfe (Riegel et al., 1950)
in the cold room. They were powdered finely and
kept in screw capped jars in a deep freeze cabinet
at -20°. The urine was worked up daily and the res¬
idues stored in evacuated desiccators at room temper-
ature.
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S) Injection of provesterone
Twelve rata as controls (control rats) were each
injected lntraper1toneally with 0,1 ml, sterilized
olive oil at 9 a.m. each day and the remaining 12 rats
('metabolic * rats) were injected in the same way with a
sterilized solution of 2 rag* of progesterone in 0,1 ml.
olive oil,
4) Determination of pregnanediol
This was carried out by the method of Klopper
et al.(1955) with the following modifications intro¬
duced by Dr Grant, In place of sintered glass discs
in chromatogram tubes, plugs of solvent-washed cotton
wool were usedj three extractions with toluene were
performed Instead of two and emulsions which formed
during these extractions were broken routinely by slow
filtration on a Buchner funnel,
5) Determination of aljppregnanediol
A search for adlopregnanediol was carried out
separately after the pregnanediol determinations were
concluded. The fact that no pregnanediol had been
detected greatly simplified the task of adapting the
method of Klopper et al,(1955) for the measurement of
adlppregnanediol. The elution pattern for this steroid
given in Table 1 (Klopper et al,,1955) showed that it
began to be eluted from the first alumina column after
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the passage of about 15 ml, of 0.8$ ethanol in benzene.
During the determinations of pregnanediol in rat urine,
it had been observed routinely that a fairly narrow
band of brown pigment began to travel down the column
when this solvent was added and it was found that 12 ml.
was the minimum volume required to elute this pigment
completely. Hence this fraction was discarded and a
further 30 ml., as indicated by the same liable, was
O(fo 4-C- - , »
found to be sufficient to recover the allopregnanediol.
k
When this eluate was evaporated to dryness, white alio-
pregnanediol could be seen together with a little gum
when recovery experiments were being carried out at the
50 {xg. level. After acetylation and rechromatography,
the petroleum ether and benzene fractions were examined
for allopregnanedicl and this was found to be in the
latter fraction.
Five ml. of Analar concentrated sulphuric acid
were used for the formation of chromogens which were
t/A
read at 400, 430 and 460 mji.on a Unicam S.P. 600
spectrophotometer, using 1 cm. glass cells, as in the
pregnanediol method. Allopregnanediol has a similar
spectrum in sulphuric acid to that of pregnanediol
with a peak at 430 mp. (Bernstein and Lenhard, 1953).
C) Examination of urine for pregnanediol
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l) After injection of olive oil
The 24 rats were allowed to become accustomed to
the diet and to the metabolism cages; olive oil
injections were then begun. The urine from 6 rats,
collected for 24 hr. was strained through glass wool
and made up to 100 ml. with distilled water. Forty
ml. of toluene were added and 10 ml, of concentrated
hydrochloric acid were used for hydrolysis; 20 ml. of
toluene were used for the second and third extractions^
and the oxidation was carried out by shaking for 15
min. with 25 ml. of freshly prepared KMn04 in
11-HaOH. For recovery experiments, pregnanediol in
ethanollc solution was added to the urine before
addition of toluensf - -W k
Klopper et al. (1955) obtained 72-104^5 recovery
after addition of 25 jxg. of pregnanediol to l/2Qth
of a 24 hr. specimen of human male urine. In order
to extend the sensitivity of the method, if possible,
recovery experiments were carried out after addition
of 50 jxg., 25 |xg. and 12 pg. of pregnanediol to a
urine specimen.
On the first day, urine from groups 1 and 2 was
used for blank determinations and urine from groups
3 and 4 for recoveries; on the second day, urine from
groups 3 and 4 was used for blanks and urine from
groups 1 and 2 for recoveries; and so on, alternately.
The volume of Analar sulphuric acid used for color-
Imetry was reduced from 10 ml, to 5 ml. to increase
the sensitivity of the method.
Table1



































































































(i) The results shown in Table 1 indicate that recov¬
eries are satisfactory at these levels.
(ii) The apparent pregnanediol values in the blanks
are fairly consistent and low*
2) After injection of progesterone solution
Exactly the same method of analysis was used as
after injection of olive oil. Groups 1 and 2 of the
rats were used as controls (injected with olive oil on
three successive days) and groups 3 and 4 were used as
'metabolic1 rats (injected with progesterone solution
on the same days). Optical densities were read at
400 m|i. and 460 mg. as well as at 430 mp.. in order to
detect any selective absorption at 430 mjt.
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Table 2
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Optical Densities
Day Rat Group No. 400 mg. 430nut. 460 m;-'-.
1 1 0.042 0.041 0.018
2 0. 040 0.039 0.015
3 0. 040 0. 032 0. 012
4 0. 041 0. C32 0. 012
2 1 0.038 0. 030 0. 020
2 0. 034 0. 031 0,018
3 0.032 0.028 0. 017
4 0.033 0.026 0.019
3 1 0. 052 0. 023 0. 012
2 0.034 0. 022 0. 009
3 0. 032 0. 021 0. 007
4 0. 035 0.021 0.010
4 1 0.028 0, 025 0. 020
2 0.030 0. 027 0. 017
3 0. 029 0, 026 0. 016
4 0. 030 0. 024 0, 018
Conclusions
(l) The optical densities are not selective at 450 up*
(ii) The values for control rats (range 4 to 7 g.g,
apparent pregnanediol) and ♦metabolic* rats (range
4 to 6 gg. apparent pregnanediol) are indistin¬
guishable.
(iii) The values do net show any change after cessation
of injections.
(iv) 6P-pregnane-3a:20a-&iol has not been detected in
the urine of the male rat after intraperitoneal
injection of three daily doses of 2 mg. progesterone
in olive oil.
Table3
Recoveryofalltvpreftnanedioladdetp ol d34hr»specim sofurinefr mgroupsf6ats BlankexperimentsRecoveryexperiments Apparentallo regnan diol inraturine (^g.)Allopregnanedioladde tourinebeforhyd- olysis (ug«)


































D) Examination of Urine for allopregnanediol
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Twelve male rats were used for this part of the
work. They were divided as equally as possible as
regards weight, into two groups of 6 and were allowed
to "become accustomed to the diet and the metabolism
cages before urine collections were begun,
l) From normal rats
The urine from 6 rats, collected for 24 hr,,
was worked up in the same way as for pregnanediol
determinations (p, 74 ) except for the chromatographic
modifications described on p, 75 , For recovery
experiments, allopregnanediol in ethanolic solution
was added to the urine before addition of toluene.
On the first day, urine from group 1 was used
for a blank determination and urine from groxip 2 for
a recovery; on the second, urine from group 2 was
used for a blank and urine from group 1 for a recovery;
and so on, alternately.
Conclusions
(i) The results shown in Table 3 indicate that
recoveries are satisfactory at these levels.
(li) The apparent allopregnanediol values in the
blanks are fairly consistent and low.
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2) After injection of progesterone solution
Group 1 of the rats was used as a control group
(injected with olive oil on three successive days) and
group 2 was used as a'metabolic* group (injected with
progesterone solution on the same three days).
Optical densities were read at 400 mp. and 460 mp. as
well as at 430 mp* in order to detect any selective
absorption at 450 mp.
Table 4
Measurement of apparent, allcrnregnanediol in rat urine
Optical Densities
5SZ Rat Group No. 400 mp. 450 mp. 46© mp.
1 1 0.056 0. 050 0. 054
2 0. 054 0, 028 0.020
2 1 0. 064 0. 057 0. 046
2 0.054 0. 047 0.044
3 1 0.061 0.052 0. 040
2 0. 041 0. 033 0. 023
4 1 0. 064 0, 058 0. 044
2 0. 066 0.060 0. 049
Conclusions
(i) The optical densities are not selective at 430 mp.
(ii) The values for control rats (range 9 to 11 pg.
apparent alloprecmanedlol) and *metabolic* rats
(range 5 to 11 pg. apparent allopregnanedio1) are
indis tinguishab le.
(iii) The values do not show any change after cessation
of injections.
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(iv) 5a-pregnane-3a:20a-diol has not been detected in
the urine of the male rat after intraperitoneal
injection of three daily doses of 2 mg. progesterone
in olive oil.
S) Examination of Pregnancy Urine for Pregnanediol
■ I i.>Ki..igi r«, ,.1,m > nil II— I «ar — i.iiwi* ... ■ I» I« I.. |»W"" *"»— I .»«*■ ||» m ..«»■■
and allonregnanediol
Although these steroids had not "been found in male
rat urine after injection of progesterone, it was still
possible that metabolism of endogenous progesterone in
the female might yield these derivatives. Accordingly,
two groups of 6 female rats were placed in metabolism
cages and fed on the same diet as that given to the
male rats. Urines were collected from both groups and
determinations of apparent pregnanediol and apparent
allooregnanediol carried out. One group was then kept
as a control group, and the other group, together with
WTIL-Q
two additional female rats were then mated. Of these
eight rats, four became pregnant; as soon as pregnancy
was detected, these four, together with two female rats,
were placed in a metabolism cage (Group 2) and the six
control rats in another metabolism cage (Group l).
Urines were collected for four days and examined for
pregnanediol and allopregnanediol. Towards the end
of the first and second 24 hr. periods, parturition
occurred with two of the rats. These were removed
from the cage and replaced with female rats.
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Table5
Measurement of apparent pregnanediol in female rat urine
Optical densities
Date Rat Group No. 400 mp.. 430 rap. 460 rati.

















Measurement of apparent allonrercnanediol in female
rat urine
Optical densities
Date Rat Group No. . 400 mp. 430 mj.1. 460 mp..


















(i) The apparent pregnanediol and allopregnanediol
values in the non-pregnancy urines are fairly
consistent and low*
(ii) The optical densities are not selective at 430 rap.
(iii) The values for non-pregnancy and pregnancy urines
are indistinguishable.
(iv) Neither 5£-pregnane-3a:20a-diolnor 5a-pregnane-
3:20a-diol has "been detected in rat pregnancy urine.
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F) Examination of Urine for 5g-pregnane-»Sa: 17ai 20a-
ptmrntrnm "i*1"— <*mam »■■■* -—> Ufa** m «tmm mUtmtma&mmmmmmMaimmi+m ■ —»«
triol tpregnane triol)
Gox and Marrian (1955) showed that this steroid
occurs in male human urine, Klopper et al,(1955)
found that, on "boiling with dilute acids, pregnanetriol
formed a number of compounds one of which, when acetyl-
ated, behaved chromatographically like pregnanediol
diacetate and gave a chromogen with sulphuric acid.
After oxidation with potassium permanganate, which
does not affect pregnanediol, the oxidation products
no longer contaminated the pregnanediol fraction.
Since, after injection of progesterone, no
pregnanediol was detected in rat urine, it was decided
to investigate the presence of any pregnanetriol by
comparison of the cliromogens produced after applying
the normal pregnanediol method and after application
of the same method, with the permanganate oxidation
step omitted.
Two samples of urine from two groups of 6 control
rats, which had been injected with olive oil, and two
samples from two groups of 6 •metabolic* rats, which
had been injected with progesterone, were examined for




Rat Group Ho# Optical Density at 450 ran.
Control groups 0#043





(i) The values obtained are not appreciably higher
than those obtained after including the perman¬
ganate oxidation (see p. 78 ).
(ii) The values from the control and the 'metabolic*
groups are indistinguishable#
(iii) It appears unlikely that 5{3-pregnane-3a: 17a:20a-
trlol is excreted in the urine of the male rat
after intraperitoneal injection of 2 rag# progesterone
in olive oil.
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G) Examination of Urine for Other Steroids
Urine samples, collected daily, from two groups
of control rats, were combined, filtered and made up
tp 200 ml, with distilled water. This diluted urine
was hydrolysed with hydrochloric acid and toluene
extracts made as in the pregnanediol method, except
that three 40 ml, portions of toluene were used for
extraction. The combined extracts were washed twice
with 25 ml, 2,5/ (w/v) ITaCl in 0,IXT-NaOH and twice with
25 ml, water; the toluene was distilled off in vacuo
at 45° on a water bath. Similarly, extracts were
made from urine samples from two groups of 'metabolic*
rats.
Injections were continued for 8 successive days
and collection of urine and faeces for a further two
days; the combined urine extracts were dried in vacuo
over PsQs,
In view of the fact that negative results were
obtained, the Girard separation is given in some
detail.
The extracts were dissolved in 10 ml, ethanol to
which was added 0,2 g, Girard* s Reagent T (Girard and
San&uleseo, 1936) and 1 ml, glacial acetic acid. They
were refluxed on a boiling water bath for 1 hr» and
then were poured quickly into 55 ml. water, 30 g.
crushed ice, a sufficient amount of HaOH to neutralize
9/10 of the acetic acid and 15 g, NaCl, This aqueous
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material was extracted once with an equal volume and
three times with half volumes of ether and the combined
ether extracts washed once with water (this washing was
added to the aqueous phase), twice with 5% NalICOs and
twice with water# The ether was evaporated and the
residues (non-hetonic fraction^ dried over Ps05• The
aqueous phases were acidified with 10 ml. 18N-II2SO^,
100 ml. ether were added and the whole allowed to stand
for 1| hr. at room temperature. The ether layers were
separated and the aqueous phases extracted further with
three 50 ml. portions of ether. The combined ether
extracts were washed twice with NaHC03 solution and
twice with water and the residues (ketonie fractions)
dried over Ps Cfe.
This Girard separation was repeated on the non-
ketonic fractions and the resulting new ketonic frac¬
tions were combined with the original ones. The




Weights of fractions from 'metabolic* and control

















l) Examination of ketonic fractions with 2;4-dinitro~
phenylhydrazine
The 2:4—dinitrophenylhydrazones of allopreg-
nanedione, pregnanedione and alloarcgnano1one v/ere
prepared by the method of Reich, Sanfilippo and Crane
(1952), These steroids were chosen as possible
ketonic progesterone metabolites in the rat, the first
and third having been isolated by Taylor (1954) in
vitro#
Alumina, activity III, was used to purify the
products# Melting points and absorption maxima of
these compounds v/ere determined and are shown in
Table 7 .
Table 7
Physical properties of some 2:4-ainitrophenylhydrazones
2:4—dlnitrophenylhydrazone of Absorption Melting
" '
Max. in cMcia point
TO
5ci-pregnane-3:20-aione 371 208-212° 3
(bis DNP1) ana
228-232°




1 DNP = 2:4-dini trophenylhydrazone.
2 Lieberman, Dobriner, Hill, Fieser ana Rhoaas (1948) reported
207-211°.
3 Reich, Crane ana Sanfilippo (1953) reported 368-369.
4 Lieberraan et al.(1948) reported 251-253°.
5 Reich et al.(1953) reported 265-267.5;©»
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A 12 mg. portion of the hetonic fraction of
control urine was treated with 3*6 ml. of freshly
prepared 2:4-dinitrophenylhydrasine reagent (Reich et
al., 1952) and the purified products taken up in 50^
benzene in hexane. This was placed on a S g, alumina
column and 20 ml. fractions were collected, using the
following solvent elution pattern:
60 ml. 50/y benzene in hexane
60 ml. 75% " ft
140 ml. benzene
40 ml. 2/S chloroform in benzene
60 ml. B%> " » M
40 ml. 10% » n n
20 ml. 2Cps " If o
20 ml. 25% " it n
20 ml. 30% " » n
2© ml. 40% " ii «
20 ml. 5€fia " II *i
20 ml. 75% " if it
20 ml. chloroform
20 ml. methanol
This system was evolved in preliminary exper
to separate the above 2:4—dinitrophenylhydrazones
(Table 7) in the presence of the hetonic fraction from
toluene extracts made from normal male rat urine. The
fractions \?ere evaporated to dryness, desiccated in
vacuo over CaCls , dissolved in 10 ml. chloroform and
■89-
their optical densities measured at 570 mp. on a Unicam
S.P# 600 spectrophotometer in 1 era. cells# This wave¬
length was chosen since the 2 s 4-dinitrophenylhydrazones
in Table 7 all have a peak in the region of" 570 mp#
This procedure was repeated with three other 12 mg*
ketonic portions from extract of normal male rat urine#
To these portions, before treatment with 2:4—dinitro-
phenylhydrazine, 100 pg# of allonregnanedione. 100 pg#
of pregnanedione and 100 pg# of ailopregnanclone,
respectively, were added# The results of these four
chromatograms are shown in Pig# 7 (opposite p# 90 ).
It can be seen that the allonregnanedione was eluted
in fi^actions 7 and 8# This was confirmed by combining
these, dissolving in 50% benzene in hexane, placing on
a 3 g# alumina column and ©luting with 20 ml# portions
of benzene in hexane of 50%, 60%, 70%, 80% and 90%
benzene; GO ml# of 95% benzene in hexane and 60 ml# of
benzene# Absorption maxima were determined on the
resulting fractions; the material eluted with 95% benzene
in hexane was found to have a maximum at 371 mp. and to
have a double melt at 205-209° and 225-330°• Similar
procedures were carried out with fractions 9, 10 and 11
(pregnanedione), material from which gave a maximum at
369 mp. and a double melt at 252-255° and 260-270°# The
same methods applied to fractions 12 and 13 (allppreg-
nanolone) gave a maximum at 373 mp. and a melting point
range of 211-219° (cf# Table 7).
40 38
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A 12 mg. portion of 'metabolic* ketonic fraction
was treated in an identical manner to the control
ketonic fraction. The resulting chromatogram is shown
in Pig, 7, To investigate the nature of the substance
in fraction 0 of the 'metabolic* ketonic material, it
was rechromatographed in the same way as above. The
resulting absorption maximum was 373 mb* but the melting
point was over the range 60-90° with a small residue
melting at 90-130%
Conclusions
(i) The 'metabolic* ketonic fraction from male rat
urine contains less than 100 bg, of the three
steroids investigated.
(ii) By the procedures carried out, it would appear
that the male rat, after Intraperitoneal injection
of 8 daily doses of 2 mg, of progesterone in olive
oil excretes less than 0,3$ of 5a-pregnane-3:20-
dione, 5fi-pregnane-3:20-dione and 3a-hydroxy-5a~
pregnan-20-one into the urine.
2) Examination of non-ketonic fractions
These were subjected to a digitonin separation
(Butler and Marrian, 1938), The control fraction was
transferred to a centrifuge tube with 5 ml. 90/, v/v
aqueous ethanol, heated to boiling, cooled, and the
insoluble matter centrifuged off. To the supernatant
solution, heated to boiling, was added a hot solution
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of 200 mg# digitonin in 20 ml. 9C$» v/v aqueous ethanol
and the mixture left for 40 lor. with occasional stirring
and scratching with a glass rod. No insoluble dig¬
itonide was formed.
The solution was evaporated to dryness in vacuo,
transferred to a 100 ml. centrifuge tube with 2 ml.
methanol and a large volume of ether added. The
digitonin precipitate was centrifuged, the supernatant
solution removed, the residue washed with 90 ml, ether,
centrifuged and the washing added to the first super¬
natant solution. The ether was evaporated off to
leave the digitonin non-precipitable non-ketonic
fraction.
The •metabolic* non-ketonic fraction was treated
in the same way; it also yielded no insoluble digitonides.
The two fractions were subjected to chromatography,
using a gradient elution starting with v/v ethanol
in benzene (Taylor, 1955). Each was taken up in
5 ml. 2>a v/v ethanol in benzene, put onto a 0.5 g.
alumina (activity II) column and eluted by an ethanol-
benzene mixture ranging from 2, v/v to 5% v/v ethanol
by a linear gradient over 200 ml., followed by ethanol
and chloroform. The main fraction, in each case, was
eluted by 2$ ethanol in benzene; unsuccessful attempts
v/ere made to crystallize this from acetone, ethanol
and methanol.
Table 8








































H) Examination of Faeces
After drying, the control and 'metabolic' faeces
weighed respectively 512 g. and 520 g. The following
procedures were carried out for "both the control and
'metabolic* faeces (weights of fractions are given in
Table 8 ); the faeces were boiled for 1 hr. with 2.5 1.
of toluene (Riegel et al., 1950) and, when cold, the
toluene was poured off and filtered on a Buchner funnel.
A second extraction with a further 2*5 1* of toluene
was performed, yielding 4,5 1* of filtrate in all;
this was boiled for 1 hr* with 4 1. of 20% w/v aqueous
K2C03 (Riegel et al,, 1950), allowed to cool and the
lower layer discarded* This procedure was repeated;
'
the toluene layer was washed four times with 1 1* of
v/ater and the washings back-extracted twice with 400 ml*
of toluene* The toluene was distilled off in vacuo
at 72° and the residue dried over CaClg, This extract
was taken up in 600 ml* of methanol, 200 ml* of n-hexane
and 200 ml* of water added, shaken vigorously and left
for 2 hr. at room temperature (Taylor, 1954), The
methanol layer was run off and the hexane back-extracted
twice with 200 ml* of 75k v/v aqueous methanol* The
combined methanol extracts were washed with 100 ml* of
hexane*
The bulk of the methanol was removed by distillation
in vacuo, 400 ml* of water added and the mixture
extracted twice with 1 1, of chloroform. The combined
chloroform extracts were washed with 200ml. of H-NaOH
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and then with water until the washings were neutral.
The extracts were dried over NasS04 and the chloroform
removed "by distillation in vacuo.
Separations were carried out using Girard's reagen
T, as with the urine. The Girard separation was
repeated on the non-ketonic fraction.
The control ketonic fraction was then subjected
to a digitonin separation (Butler et_ al. , 1938), as
described under the control urine non-ketonic fraction
(p« 90 ) except that 300 rng. of digitonin were used.
The white crystalline digitonide was centrifuged, the
supernatant solution removed, the residue washed twice
with small volumes of 9(%o v/v aqueous ethanol, once
with ether and the washings combined with the super¬
natant solution. The residue was dried in vacuo over
CaCljj.
The dried digitonide residue was dissolved in
0.5 ml. of pyridine and 10 ml. of ether added. The
digitonin was centrifuged off, the supernatant solution
transferred to a separating funnel, the residue washed
with ether, centrifuged and the washing added to the
separating funnel. The ethereal solution was washed
with 2N-HaSO*, twice with water and the ether evap¬
orated to leave the digitonin precipitable control
ketonic fraction.
The 'metabolic* ketonic fraction was subjected
to a digitonin separation in the same way, as also were
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both non-Icetonic fractions# using 720 mg, of digitonin
in 60 ml. of solvent for the latter two.
Investigation of fractions
1) Digitonin non-precipitahle hetonic
The 'metabolic1 fraction was dissolved in 10 nil.
benzene, put on a 2 g. alumina (activity II) column and
eluted as follows:
2 x 10 ml. benzene
10 ml. 2$ ether in benzene
10 ml. 2% " " "
10 ml. 5% " " "
10 ml. 1G£ " " "
10 ml. 20^ " " "




The main fraction, 27 mg.# was obtained on elution with
benzene| various solvents# including acetone and ethanol,
were used in attempts to obtain crystalline material,
but without success.
The control fraction was treated in the same way
and the main portion was eluted at the same point as in
the 'metabolic* chromatogram, the weight being SB mg.
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2)Digitonin procipitable kc tonic
Attempts were made to crystallize the control
fraction (l rag.) and the ♦metabolic* fraction (3 nig.)
from acetone, "but contamination with yellow gum prev¬
ented this.
o) Digitonin non-precipitable non-ketonic
These were yellow gums; they were dissolved in
5 ml. v/v ethanol in benzene, put on 3 g. alumina
(activity II) columns and eluted by the same procedure
as used for the corresponding urine fraction (p. 91 ).
With the 'metabolic* material, two main fractions were
obtained; the first (18 mg.) was eluted with ethanol
in benzene and after attempted crystallization from
acetone and methanol, the semi-crystalline material
obtained sublimed partially at 370° and melted at 310-
320°. The other main fraction (21 mg.) was eluted
with chloroform; it was still gummy and could not be
purified further. The control material gave similar
results, the corresponding fractions both weighing
20 mg.
4) Digitonin precipitable non-ketonic
These fractions were both white, but not cryst¬
alline. In the case of the control fraction, cryst¬
allisation from ethanol yielded white crystals with a
ra.p, 101-104°. Mixed with authentic coprostan-3£3-ol
(m.p. 101-103°) the m.p. was 101-104°. Application
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of the Liebermann-Burchard reaction (Kerr and Bauld,
1953) to residues obtained from the mother liquors
gave a faint green colour.
Crystallization from ethanol and other solvents
was attempted ?/ith the metabolic fraction, but was not
achieved.
Conclusion
.. t - » •
No known metabolites of progesterone have been
found in the urine or faeces of the male rat after
intraperitoneal injection of a solution of progesterone
in olive oil.
SECTION IV




Heaven (1955) has shown that steroids with an
cxp-unsaturated ketonic group in King A lose their
absorption maximum at 240 ran. after incubation with
human liver# As a possible research project, the
author considered isolating the metabolic products
resulting from the incubation of progesterone with
human liver homogenate. With this end in view,
experiments were done to find optimum conditions; rat
liver was used for this purpose, since it was readily
available and the assumption had to be made that these
conditions would hold for human liver.
Since DEN is fairly expensive, it was decided to
reduce the final incubation volume from 5 ml. to 2 ml.
The following substances were present unless otherwise
stated: O.lM-nicotinamide; 0.04M-Tris buffer, pll 7.4;
0. OlM-sodium citrate and 0.0Q5M-KnSCu. Homogenization
v/as carried out in 0.25M-sucrose, or in Q#25M-sucrose
containing nicotinamide to give a final molarity of
0.1 and, except where otherwise stated, a 2&% homogenate
was used. 1 ml. of homogenate was added to each
flask.
B) The Effect of Storage Temperature
Since it was not known when human liver would be
available, optimum conditions of storage had to be
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ascertained; these would "be required while incubation
flasks were prepared prior to hornogenisation of the
liver.
Equal portions of the same rat liver were:
1) homogenized Immediately and incubations begun, at once;
2) stored at 0° for 24 hr# and then homogenised;
S) stored at -20° for 24 hr# and then homogenized#
Results
After incubation Progesterone recovered
Tasn m
Fresh liver 25 5
50 10
Liver stored at 0° 30 6
60 12






(i) Storage of whole liver at 0° for 24 hp# does not
affect its capacity to destroy progesterone.
(ii) Storage at -20° reduces the capacity to destroy
progesterone#
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C) Comparison of Hornogenization in Sucrose and in
Sucrose-N i co tinainide
1) In absence of added DPNH
Where homogenization was done in sucrose,
nicotinamide was added to the incubation flasks to
give the same final concentration (O.Bl),
Results
After incubation Progesterone recovered
-ohd m
Prepared in sucrose 816 81
858 84





2) In presence of added 0.00Q2M-DPHH
Results
After incubation Progesterone recovered
(bg«) CPT
Prepared in sucrose 230 22
272 26







Nicotinamide aids the destruction of progesterone
more effectively when present in the homogenizing
medium than when added later, whether in the absence
or presence of added DPNH,
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D) The Effect of Varying Nicotinamide Concentration










•Controls1 0.06 987 96
1019 99
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With 25% horaogenate, the optimum nicotinamide
concentration is about 0.1M and with 10% homogenate
it is somewhat lower than this.
























Previous experiments (with supernatant) had shown
that O.QIM-citrate was more effective than 0.002M,
This experiment shows that with 25$ homogenate, the
effectiveness of citrate as an *aetivator* of progest¬
erone metabolism is not increased above a concentration
of o,oua,
F) The Mode of Addition of DPIIH
Instead of the usual addition of coenzyme in bulls;
at the beginning of the incubation, the effect was
tried here of adding coenzyme in six equal portions,
every 10 rain., starting with the commencement of the
incubation.
Results
After incubation Progesterone recoveredu s iiSi'u eu?
(jig.) un














Metabolism is greater when DPNH is added in
portions than when added in bulk before incubation.
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G) The Effect of 0. OlM-tpans-aconitate
In order to investigate the role of citrate, the
effect of trans-aconitate. which inhibits the conver¬
sion of cis-aconitate to isocitrate, was tried. A
lQ?<i homogenate was used with 0. 06M-nicotinamide; 0, Q1M-
citrate was added only where shown,
Results
After incubation Progesterone recovered
(dg«1 (^T
No additions 4-07 80
412 81
With trans-aconitate 438 86
449 88
With citrate 321 63
332 65





The destruction of progesterone is inhibited by
trans-aconitate both in the absence and in the presence
of added citrate.
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H) Modification of the Klopper Method for the Determin¬
ation of Pregnane7r£oT~arid. allooregnanediol in the"
presence of Liver Tissue
In view of the failure to detect pregnanediol or
allopregnanediol in rat urine after the injection of
progesterone (Section III) it was decided to search for
these metabolites after the incubation of progesterone
with rat liver homogenate. It was possible that
these steroids, if produced, might be conjugated with
glucuronic acid and so acid hydrolysis would be necess¬
ary to release the free steroids for extraction. It
was felt that adaptation of the method of Klopper et al.
(1955) for the determination of pregnanediol in urine
(Section III) would yield the most promising results,
and this was effected as described below.
Incubations were carried out in Quickfit & Quartz
test tubes with B19 sockets, using 1 ml. of a 25?o
homogenate prepared in 0.25M-sucrose containing 0.3M-
nicotinamide, in a final volume of 5 ml. The incub¬
ation medium consisted of 0.04M-Tris buffer, pll 7.4;
0.OlM-sodium citrate and 0. 005M-MnS04• 'Control*
experiments were carried out by incubating rat liver
homogenate with the medium described above and then
adding 12 pg. of pregnanediol or allopregnanediol in
ethanolic solution. Since Grant and Marrian (1950)
showed that rat liver destroys pregnanediol, the mixture
was boiled before addition of steroid. Five ml. of
toluene were added, the tube attached to a reflux
condenser and the mixture boiled again over a wire
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gause using a micro-Bunsen. For experiments other
than 'controls' the preliminary boiling was omitted.
The tube was detached from the condenser and 0.3 ml.
of concentrated hydrochloric acid added. The tube
was re-attached and the contents boiled for 10 min.
By careful adjustment of the flame, it was found that
'bumping' was not excessive, but use of a wider and
longer tube, such as the Quickfit & Quarts with B24
socket, would facilitate this operation. At the end
of the hydrolysis the condenser was rinsed down with a
few ml# of toluene. The tube was detached, its walls
rinsed down with toluene, and cooled rapidly. The
tube was centrifuged at 2,400 r.p.m. for 5 min. to
clear the emulsion. The toluene layer was sucked over
into another test tube of the same type, using the
adaptor and U-tipped suction tube B described by Taylor
(1954-). The aqueous phase was re-extracted twice
with 5 ml. volumes of toluene, shaking vigorously both
times and again clearing emulsions by centrifugation.
To the combined toluene extracts were added 10 ml. of
a fresh #' solution of KMnQ* in N-NaOH, and the tube
shaken by hand for 5 min. The mixture was transferred
to a separating funnel, the aqueous phase discarded
and the toluene layer washed with four or five volumes
of 50 ml. water to remove permanganate. Direct
transference of the toluene layers from the original
incubation tube to a 100 ml. separating funnel fitted
Table9
Recoveryofpregnanediola dllo- rcgnan dioladdt tlivhomo nate BlankExperimentsRecoveryExperiments Apparentpregnanediol
inratliverhomogenate (Hg«) 9 10
Pregnanedioladdedto ratliverhomogenate Beforehydrolysis (Mg*) 12 12 12 12AsNaPGj(As ("






























with a B19 socket would eliminate the use of a second
test tube. The toluene solution was filtered into a
round-hottomed flask and distilled to a hulk of about
10 ml,, thereby removing water and reducing the volume.
The procedures thereafter, for pregnanediol and alio-
pregnanediol, were the same as those described in
Section III. Preliminary experiments with pregnane¬
diol showed that this method gave recoveries of 67%
or better.
The following experiment was carried out in one
operation so that conditions would be identical through¬
out. To check the efficiency of acid hydrolysis in
the presence of liver tissue, NaPG (in ethanolic
solution) equivalent to 12 jig. of pregnanediol, was
added both to the incubation medium plus rat liver
homogenate and to 5 ml. of water. Blank incubations
were carried out for pregnanediol with 3 ml. of water,
and for pregnanediol and aliopregnanedio1 with incub¬
ation medium plus homogenate. One mg. of progesterone
was added to incubation vessels (except blanks and
steroid 'controls1)j the last six tubes were worked up
for progesterone (two blanks, two •controls* and two
incubations) in order to measure the amount of progest¬
erone metabolized.
The results are given in Tables 9 and 10.
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Table 10
Measurement of apparent pregnanediol after incubation
of" progesterone with f¥C'llyer~hbr;or;enate
Optical Densities
400 ||fc 430 rpu 460 gfe
Blanks 0.059 0.042 0.039
0. 059 0. 044 0, 040
Incubations 0.051 0.041 0.036
0. 052 0. 043 0. 038
Measurement of allooregnanedlol fraction after incub¬
ation of progesterone wi't'h rat liver Komorena'te'
Optical Densities
400 mp.. 450 ran. 460 rap.
Blanks 0.050 0.048 0.032
0. 055 0, 051 0. 034
Incubations 0.184 0.180 0.151
0.153' 0.142 0.104
Measurement of progesterone recovered after incubation









(i) The apparent pregnanediol and allongegnanedlol
values are consistent and low.
(ii) Recoveries of pregnanediol and allonregnanediol
are satisfactory for a level of 12 |ig.
(iii) Hydrolysis of NaPG in the presence of liver
tissue does not appear to "be complete, judging from
the lower recoveries; hydrolysis in the absence of
tissue appears to he complete in view of the higher
recoveries#
(iv) By subtracting the mean value for the incubations
from the mean value for the 'controls* it is found
that about 570 ug. of progesterone have been met¬
abolized.
(v) Assuming only 5G£j recovery of pregnanediol, if
present as glucuronide, it appears that 5(3-pregnane-
3a:20a-diol constitutes less than 3$of the metabolic
products obtained after incubation of progesterone
with rat liver homogenate.
(vi) In view of the fact that the optical densities
obtained in the case of the allopregnanediol
fraction were not selective at 430 md* no definite





A) Interaction between Nicotinamide and Coenzymes
Tomkins et al.(1954) showed that the reduction of
the double bond of cortisone by an ammonium sulphate
precipitate prepared from a rat liver supernatant
(78,000£) required only TPNH as a coens^me# This
preparation also catalysed the disappearance of absorp¬
tion at 240 mjj- of progesterone and other cp-unsaturated
ketonic steroids, provided that TPNH was present# The
present author has found (p# 57) that a dialysed super¬
natant (150,00G£) also required TPNH for metabolism of
progesterone and that the activity of the microsomal
fraction was increased by DEN, or better, DPNH (p# 30),
in the presence of which 150,000£ supernatant was in¬
active (p# 39). The activity of 5,000jg and 26,0G0£
supernatants was increased by the addition of DEN and
still more by DPNH or TPNH (p. 47) and the activity of
a dialysed 5,00Gjg supernatant was restored by DEN (p.44;
Taylor (1954) showed that the activity of rat liver
homogenate was increased by DEN# Hence it is surprising,
at first sight, that Wiswell et al.(1953) failed to
obtain any marked increase in activity upon addition of
DPN to rat liver homogenate; however, this may be
explained by the present studies with nicotinamide.
It was found that with a given tissue concentration
there was an optimum nicotinamide concentration; if the
tissue concentration vere decreased, the optimum nicot¬
inamide concentration was also decreased (p. 101).
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The purpose of the nicotinamide is to inhibit destruc¬
tion of coenzymes by a nucleosidase present in liver
tissue (Mann and Quastel, 1941; Handler and Klein,1942)i.
The former workers allowed that if the nicotinamide
concentration were too high* then partial inhibition of
other enzymes occurred, for example, lactic dehydrogen¬
ase, and they attributed this effect to competition of
the nicotinamide with coenzyme for the lactic dehyd¬
rogenase. The inhibiting effect on progesterone
destruction caused by higher nicotinamide concentrations
was possibly due to a similar effect, namely, competition
between nicotinamide and the coenzyme for the steroid
enzyme. Thus the optimum nicotinamide concentration
may have been that which inhibited coenzyme destruction
"
. . • ' ■■ ' •
without undue inhibition of interaction between steroid
enzyme and coenzyme. With higher tissue concentrations,
the endogenous coenzyme concentration was higher, and
a higher nicotinamide concentration was necessary for
its protection. Wiswell et al. (19515) used a low
tissue concentration (2%) and when 0.OOGmM-DPIT was
added to flasks, 40 mM-nlcotinaml&e was also added;
this was a relatively high concentration of nicotinamide
to coenzyme (endogenous and added) and may explain the
fact that only a sli^it increase in progesterone
destruction was observed.
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3) The Role of Citrate
With 25fo homogenate, Increase in the concentration
of citrate above 0#01M aid not increase its activating
effect (p# 101). As mentioned above (p# 109) Tomkins
et al» (1S54) found that TRJH was the coenzyme required
by the supernatant; they provided it by addition of
TPN in presence of a reducing system, such as glucose-
6-phosphate and glucose-6-phosphate dehydrogenase, or
isocitrate and isocitric dehydrogenase# Since the
latter enzyme occurs in the supernatant, it appeared
to the author that the powerful activating effect of
citrate might be due to the following series of
reactions:
citrate^cis-aconltate^isocitrate oxidized^. <*5a-pregnane~
y 3:20-dioneI coenzyme I
a-oxo-glutarate at Nk. reduced -/V.progesterone
igocitric "5a-reductase"
dehydrogenase
This mechanism was published first by Taylor (1955);
it is substantiated by the fact that Wiswell et al»
(1953) found that eouimolar concentrations of citrate,
cis-aeonitate and isocitrate were equally effective
for increasing progesterone metabolism by rabbit liver
homogenate; Taylor (1955) has shown since that the
enzyme systems responsible for metabolism of progesterone
in rat and rabbit livers have similar properties
with regard to coenzyme requirement#
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Further support for the coensyme-reducing role of
citrate was given by the fact that whereas 25,000£
supernatant reduced TEN rapidly, dialysed supernatant
did so much more slowly (p, 51 and Pig, l) but the
addition of iopcitrate to the latter brought about
rapid reduction of TEH (p, 49),
Wiswell et al,(1953) proposed that citrate increased
progesterone metabolism by chelation with an inhibiting
metallic ion; this suggestion was supported by their
own findings that two other metal-binding substances,
cysteine and cyanide, increased metabolism also, in
fact to a greater extent than did citrate. To
investigate further this point, the effect of the well-
known chelating agent, Versene, was tried (Altmannand
Crook, 1955), It was found to have no appreciable
influence and, unlike citrate, it did not increase the
metabolism of progesterone (p, 46), Since the conver¬
sion of cis-aconitate to isoeitrate by aconitase is
inhibited by trans-aeonitate, the effect of addition of
this substance was tried (p* 103), It was found to
cause inhibition of progesterone metabolism, thus
supporting the coenzyme-reducing role of citrate*
These findings cast doubt on the theory that citrate
functions by chelation with inhibiting metallic ions
since the presence of trans-aconitate should not
diminish this process. It is a possibility that the
fact that Wiswell et al,(1955) obtained increased
•"US-"
progesterone metabolism by addition of cysteine or
cyanide, was due to the presence of an inhibiting
metallic ion in the water or reagents used* As an
example of this type of phenomenon Judah and Rees
(see Altmannet al#, 1953) found that histidine, which
chelates heavy metals, no longer increased the activity
of the succinic oxidase system if the mitochondrial
preparation was made carefully with glass-distilled
water and pure reagents were used#
C) Metallic Ions
Adler, von Euler, Gunther and Plass (1939) showed
that isocltric dehydrogenase catalysed the reduction of
TEN by isocltrate and that the system required Mg or
Mn+"f, the latter being more effective* It was found
(p. 45) that metabolism of progesterone by 5,G00r?
supernatant was greater with added Mn++ than with Mg++.
In the case of a dialysed supernatant in which
isocitrate was absent almost completely, this reduction
of TEN by isocitric dehydrogenase could not take place
and therefore the absence or presence of Mg or Mn
should not have affected progesterone metabolism, as
far as this aspect was concerned* Progesterone
metabolism by dialysed supernatant was indeed found to
be independent of Mg++ or Mn++ (p# 57) *} under these
conditions, TPNH was acting stoichiometrically, there
being no enzyme systems available for the reduction




Spectrophotometry studies (p. 51 and Pig. l)
showed that 25,000£ supernatant reduced TEN, Thus it
was difficu.lt to understand why coenzymes were much
more effective if they were reduced before addition to
the incubation vessels (p. 47); this is possibly
accounted for by the fact that although DEN and TPIT are
attacked by a nucleosidase found in mammalian central
nervous system, BPBH and TFNH are not (Mcllv/ain and
Rodnight, 1948). However, it does not follow that
liver nucleosidase has the same properties and, indeed,
Axelrod (1955) reported that these reduced coenzymes
disappeared rapidly in the presence of rabbit liver
microsomes (and nicotinamide), even in the absence of
substrate. This probably explains why DEKII added in
portions at intervals, was more effective than when
added in bulk at the commencement of incubation (p. 102),
Although supernatant specifically requires TPHH
for progesterone metabolism (Tomkins et al,, 1954),
homogenate (Taylor5 1954), 5,OC0£ supernatant (p. 4S) ,
25,000£ supernatant (p. 47) and microsomes (p. 5<r ) were
able to utilize DEN or DEMI, There are twro possible
explanations for this, both of which may hold. Mehler,
Korriberg, Grisolia and Oehoa (1948) showed that pigeon
liver contains an enzyme which converts DPI! to TEN and
a similar enzyme may exist in rat liver. The progest¬
erone metabolising enzyme in the microsomes may be
able to use DENH as a coenzyme, in addition, possibly,
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to TPNH; if this is the case, it could couple with a
DPN-dependent isocitric dehydrogenase reported by Plaut
and Sung (1954) to be present in rat liver. Glenn
et al. (1956) found that absorption at 240 mp*, due to
cortisone, was diminished by incubation with a washed
microsomal fraction prepared from a rat liver homogenate
and this destruction of cortisone was increased by
addition of TPNIi.
E) The Fractionation of Rat Liver Homogenate
It was found that the nuclear fraction did not
metabolize progesterone to any degree, yet when this
fraction was removed from homogenate the resulting
supernatant was not as active as the original homogenate
(p. 29). That this was not due solely to an ageing
effect was shown when a 700£ supernatant was found to
be less active than the same homogenate stored during
the preparation of the sui3ernatant(p. 50). The results
might be explained by the fact that the synthesis of
DPN by the homogenate occurs mainly in the nuclei
(Hogeboom and Schneider, 1952b). These workers found
that the BPN-synthesizing enzyme, which is a water-
soluble protein (Kornberg, 1950), was released into
solution if the nuclei were disintegrated by sonic
oscillations. Thus it would be possible to test the
above explanation by adding the supernatant from dis¬
integrated nuclei to the 700£ supernatant, when the
116-
original activity of the homogenate should he restored,
at least to some degree.
The mitochondrial fraction alone was also found
not to he active to any extent (p, 52) yet removal of
it from a 700g supernatant, to yield a 5,000^ super¬
natant, caused a drop in activity and this was partially
restored when the mitochondrial fraction was resuspended
in the 5,00G£ supernatant (p, 55), Again, as in the
case of the nuclei, the effect ml$it he explained hy
contribution of DHT from mitochondria. Hunter, Levy,
Davis and Carlat (1956) reported that DRJ can pass out
through the mitochondrial membrane. The inactivity
of mitochondria alone mi$it he explained hy the possib¬
ility that this membrane was acting as a harrier to the
entry of progesterone, though this was unlikely since
Brownie, Grant and Davidson (1954) achieved lip -hydroxy1-
ation of progesterone with intact adrenal mitochondria;
however, liver mitochondria still required investigation,
Berthet, Berthet, Appelmans and De Duve (1952)
showed that acid phosphatase was released from rat liver
mitochondria in soluble form when they ?;ere subjected
to various treatments, including dilution with distilled
water, freezing and thawing, and ageing at 0°, The
results on p, 37 appear to indicate some metabolism of
progesterone both by intact and damaged mitochondria;
however, Schneider (1953) reported that mitochondria
prepared by the above technique (p, 9) contain about
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5% of the microsomes and these may "be responsible*
since they have been found to metabolize progesterone
(pp. 38, 39 and 40).
When the nuclear and mitochondrial fractions were
combined, fair activity was obtained (p. 35); this
illustrates well the interdependence of cell fractions.
Forchielli and Dorfman (1956) also obtained reduction of
King A when they incubated ll-deoxyeortisol (17a:21-
t '» > l
&ihydroxy-pregn-4~ene-3:20-dione) with a 6,000g residue
from a rat liver homogenate.
The activity of the microsomal fraction was
increased by DPN and still more by DHIH (p. 38);
complete inhibition occurred with 0.OOlK-p-chloromercuri-
benzoate and this was reversed partially by 0.GGlM-
reduced glutathione (p. 40). Tonkins et al.(1954)
found that the reduction of dihydrocortisone (17a:21-
dihydroxy-5p-pregnane-3:11:20:-trione) by their enzyme
from rat liver supernatant was also inhibited completely
by 0.0005M-p-chloromercuribenzoate and this inhibition
was reversed by 0.005M-gLutathione or cysteine.
These results were confirmed by Glenn et al.(1956)
?/ho found that their microsomal enzyme, from rat liver,
which reduced the double bond of cortisone,was inhibited
completely by 0.003M-p-chloromercuribenzoate. This
does not, however, enable one to draw the conclusion
that the steroid-reducing enzyme is of the sulphyclryl
type, since the above workers showed also that the same
concentration of p-chloromercuribenzoate inhibited
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strongly glucose-6-phosphate dehydrogenase, thus
suggesting that the inhibition of the steroid enzyme
was indirect* due to inhibition of the TFNH generating
system.
In the experiment on p. 42 a 5,QG0£ supernatant
was divided into three equal portions, one being stored,
at 0° while the other two were separated into microsomal
fractions and 25,000£ supernatants. One of these
supernatants was used as such but the microsomal pellet
in the other tube was suspended back into its own
supernatant. The activity of the latter preparation
might have been expected to be equal to the original
5,Q00£ supernatant. It was found, however, that only
part of the activity was regained; it will be recalled
that the same phenomenon was observed with the mito¬
chondrial fraction (p. 55) and with the nuclear fraction
(p. 50).
This effect is at least due in part to enzyme lability
since a 5,000£ supernatant prepared directly, without
decantation of the intermediate VOOg supernatant, was
more active than a 5,000£ supernatant prepared in the
normal way (p. 55). When rat liver homogenate was
centrifuged at 11,000£ and the residue resuspended,
Glenn and Recknagel (1955) observed enzyme lability
with regard to removal of the side-chain of cortisone;
they found also that hornogenate lost activity while
stored at 0° (cf. p. 53). This loss of activity may
be explained by the fact that the concentration of DEN
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and DEMI in liver tissue is reduced markedly "by homog-
enization, even at 0° (Prunder and Richter, 1985),
Unlike homogenate, whole liver (p. 98) and 5,000^
supernatant (p. 41) were found to be stable whoa stored
at 0°| however, when liver was cooled to -20° and allow¬
ed to thaw, some of the enzyme activity was lost (p.98),
The complex relationships between cellular struct¬
ures are well shown by the findings that of the four
main cell fractions, two (microsomal and supernatant)
were involved directly in the metabolism of progest¬
erone, while the other two (nuclear and mitochondrial)
contributed only when combined together.
P) Inhibition of Progesterone Metabolism
GA has been found to inhibit the destruction of
both progesterone and DOC by rat liver homogenate
(pp. 64-66). This may mean that the reduction of
Ring A of op-unsaturated ketonic steroids is inhibited
in general by OA.
This inhibition could occur in two ways; GA could
prevent the regeneration of TRIH (compare the inhib¬
ition by p-chloromercuribenzoate discussed above, p.117),
or it could inhibit directly the reduction of progest¬
erone. The former possibility is unlikely since GA
did not affect the degree of reduction of TEN by the
concurrent oxidation of glucose-6-phosphate by glueose-
6-phosphate dehydrogenase (p. 70 and Pig. 5). To test
the latter possibility, a 25,000£ supernatant was
•120-
dialysed (to remove citrate, cis-aconitate and iso-
citrate) and TRJH was added; thus the only reaction
■ i .j. . , t-.- . *.•> ;
. ' - >
that should have occurred, as far as progesterone was
concerned, was the reduction of progesterone by enzyme
and preformed TPNH, GA was added to this system and
was found to cause complete inhibition (p. 67), Thus
it may be concluded that inhibition by GA is a direct
effect on the steroid enzyme.
The fact that DGA inhibits to a small extent only
(p. 69) demonstrates that the 11-keto group is required
for inhibition, GA, administered to Addisonian patients
maintained on DOG, was found to have a DOC-sparing
effect In that it assisted in the maintenance of a
positive sodium balance (Groen et al,, 1951); Groen,
Willebrands and Pelser (1956) found that analogues of
GA, without the 11-keto group, when administered to
patients did not maintain a positive sodium balance,
characteristic of GA, This agreement between in vivo
and in vitro results supports the postulate that GA
acts in vivo by inhibiting steroid reduction.
The requirement for a keto group and the fact that
methyl vinyl ketone and p-quinone, wnich both contain
op-unsaturated ketonic groups, inhibited progesterone
reduction (p, 69), though not proof, is suggestive
that the op-unsaturated ketonic group of GA is the
active part of the molecule. Simpler ketones such as
acetophenone and acetone inhibited to a small extent
only (p, 69), The structures of these compounds are
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given in Fig.4 opposite p» 59,
To investigate whether methyl vinyl ketone is a
specific or a general enzyme inhibitor, the effect of
it on glucose-6-phosphate dehydrogenase was tried
(p. 70 and Fig, 6), It was found not to affect the
degree of oxidation of glucose-6-phosphate and hence
the concurrent reduction of TEN; nor did it inhibit
llp-hydroxylation of DOC to any marked extent (p, 71),
Thus it may be concluded that inhibition by methyl
vinyl ketone is a direct effect on the steroid enzyme.
It is possible that both OA and methyl vinyl ketone
would inhibit also the reduction of 11-keto steroids
to 11-hydroxy steroids,
* j
Q) In vivo Metabolism of Progesterone in the Hat
i !!*■> illi n»n4 .. m in on in nn — m,. ... » „ , iilti ni»»h i Uni. E" '■« ■
Neither pregnanediol (p, 78) nor allourepnanediol
(p, 80) was detected in rat urine before or after
intraperitoneal Injection of progesterone, or during
pregnancy (p, 82), The analytical methods used would
have detected as little as 6 jig, of pregnanediol or
allopregnanediol, an amount equivalent to 0,05J" of the
progesterone injected. Thus it may be concluded that
these metabolites are not excreted In significant
amounts in rat urine.
To recover allopregnanediol from rat urine, the
method of Klopper et al,(1955) for pregnanediol was
modified; the finding that pregnanediol was not detected
in rat urine meant that it was not necessary to attempt
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to separate these two stereoisomers, which facilitated
greatly the modification for allopregnanediol. However,
it might he possible, by adjustment of the nature and
volume of eluting solvents to determine simultaneously
both these steroids in one sample of urine.
The presence of pregnanediol or its glucuronide
has been demonstrated in the urine of pregnant women
(Marrian, 192S), non-pregnant women (Venning and Browne
1937), men (Engel, Than and Lewis, 1941), pregnant mares
(Marker, Kamm, Crooks, Oakwood, Lawson and Wittie,1937),
pregnant chimpansees (Pish, Dorfman and Young, 1942),
pregnant rhesus monkeys after injection of progesterone
(Boscott, 1952), bulls (Marker, Wittle and Lawson, 1938)
but not steers (Marker, 1939) and in the urine of male
and female rabbits after subcutaneous injection of
progesterone (Hoffman, 1942). However, it was not found
in the urine of stallions (Marker et al.,1938), pregnant
sows (Marker and Hohrmann, 1939), female goats after
injection of progesterone (Grant, 1950; Boscott, 1952)
or pregnant cows (Stevensen, 1947; Hill, Petersen and
Cohen, 1954; Klyne and Wright, in the press). The fact
that Marker et al.(1938) obtained crystalline pregnanediol
from pregnant cow urine may be attributed to contamination,
possibly with cow faeces. Pearlman and Cerceo (1948)
obtained 5p-pregnane-3a:20(3-diol and pregnanolone from
the bile of pregnant cows, but pregnanediol was not
detected.
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The presence or allppregnanediol has been demon¬
strated in the urine of pregnant (Hartmann et al. ,1955)
and non-pregnant women, pregnant mares, bulls and preg¬
nant cows (Marker et al», 1958), though this latter
finding is suspect, as mentioned above for pregnanediolj
also in the urine of men after intramuscular injection
of progesterone (Kyle et al,, 1951), Allppregnanediol
was not found in the urine of pregnant chimpanzees
(Fish et al,, 1942), pregnant sows (Marker et al,,1959)1
steers (Marker, 1959) or stallions (Marker et al.,1958),
Thus it is well established that there are differences
amongst mammalian species for the urinary excretion of
pregnanediol and allppregnanediol.
Dorfman (1954) has indicated that pregnanetriol
may be a metabolite of 17a-hydroxyprogest®rone but this
has not been established experimentally yet, Ungar,
Davis, Rosenkrantz and Dorfman (1954) isolated 10 mg,
of pregnanetriol from the urine of a 66 years old woman
with rheumatoid arthritis after oral administration of
a total of 2,4 g, of 17ai21-dihydi*oxy—5p-pr©gnane-3J20-
dione. Three mg, of pregnanetriol were isolated from
the post-treatment urine, but none from the pre-treatment
urine.
The permanganate oxidation step of Klopper et al,
(1955) is designed to degrade any ethylenic compounds
derived from pregnanetriol during hot acid treatment.
If this step is omitted, chromogenic material derived
from the pregnanetriol is found in the pregnanediol
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fraction (Klopper et al#, 1955)* Thus, in the absence
of pregnanediol, this could be used as a test for the
presence of pregnanetriol# Since pregnanediol had
indeed not been found (p# 78), it was decided to exam¬
ine the urine for pregnanetrioi although this may not
be a progesterone metabolite; none was detected (p. 84)#
Examination of the urine for allopregnanedione ,
pregnanedionc and allopregnanolone , using the dinitro-
phenylhydrazine technique, failed to reveal the pres¬
ence of these steroids (p# 90)# This does not con¬
stitute proof, however, that they are not excreted in
rat urine, since adequate controls were not carried
out# These steroids, in ethanolic solution, should
have been added to rat urine instead of to the ketonic
fraction from rat urine#
Examination of the faeces and of the non-ketonic
fraction of the urine, did not result in the isolation
of any crystalline material, except for coprostan-3£-ol,
which is known tc occur in faeces and so was only ident¬
ified tentatively by m.p. and mixed m#p# (p. 95)#
Siegel et al#(1950) who injected progesterone-21-
cid- rats, showed that some radioactivity, which
was not due to progesterone was recovered in the ket-
onic, non-alcoholic fraction from the faeces# In view
of the metabolites isolated by Taylor (1954) this rai$it
have been pregnanedione or alloprcgnanedione# Only
the latter forms an insoluble digitonlde (Butenandt and
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Mamoli, 1955) and the corresponding ketonic, digitonin
precipitable metabolic fraction, isolated in the pres¬
ent work, wei^ied only 3 mg. and yielded no identifi¬
able products (the corresponding control fraction
weighed 1 mg. ).
This non-alcoholic ketone, found by Riegel et al.
(1950) in rat faeces, might be the same substance as
the Compound X which was an ct£-unsaturated, non-alcoholic
ketone isolated by Pearlman et al.(1948) from the bile
of pregnant cows. Grady et al.(1952), after injection
of progesterone-21-C1* into rats, found that about 75/S
of the radioactivity was recovered in the faeces, but
did not identify any compounds therein# Shen et al.
(1954) using also progesterone-Sl-C1^, showed that oxid¬
ative fission of the side-chain must have occurred since
part of the radioactivity was recovered as COg (15%)
and urinary urea (0.5%) in the rat.
H) The Possible Conversion of Progesterone to Androgens
ana Other Steroids
It is considered by some workers that progesterone
exerts androgenic effects, for example, when injected
subcutaneously into immature castrated rats (Greene,
Burrill ana Thomson, 1940). M&rrian (1938) suggested
that allopregnanes mi$it be degraded in vivo to andro-
st&nes. Longwell and Gassner (1947) found that the
pregnant cow, unlike the bull, steer or non-pregnant
cow, excretes considerable quantities of androgens in
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the faeces. This became evident shortly after gest¬
ation and reached a maximum daring the last two months
of pregnancy. The activity was demonstrated "by feeding
the dry faeces to 10 days old chicles when, after three
weeks, the comb growth was markedly greater than that of
control chicks; progesterone itself was found to be in¬
active. The active substance was shown to be neither
testosterone nor a 17-ketosteroid but it possessed, in
ethanolic solution, maximum absorption at 240 mg., char¬
acteristic of op-unsaturated ketonic steroids. Again,
this could be the same substance as Pearlman* s Compound
X, isolated from pregnant cow bile. Miller and Turner
(1955) reported a similar effect after injecting progest¬
erone into male and non-pregnant bovines; the male and
female faecal androgen content, as measured by comb re¬
sponse in cockerels, was increased significantly.
Miller, Turner, Fufcushima and Salomon (1956) in¬
jected progesterone into a pregnant cow and examined the
faeces. Androsta-li4-diene-3:17-dione was isolated in
crystalline form and androst-4-ene-5:17-dione, androst-
ane-3:17-dione and 5P-androstane-3:17-dione were iden¬
tified partially also. The value of this work would
have been increased if the faeces of pregnant and non¬
pregnant cows had been analysed also. These substances
could have arisen either by bacterial action in the
gastrointestinal tract or by actual in vivo formation;
androst-4-ene-3:17-dione could have been derived from
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the adrenal gland (von Euw and Reiehstein, 1941). It
is interesting to note the work of Slaunwhite at al.
(1956) who identified partially 17a-hydroxyprogesterone
androst-4—ene-3:17-dione and testosterone after inuub-
ation of isotopically labelled progesterone with rat
testis; 17a-hydroxylation of progesterone in the female
could occur in the adrenal gland (Ilechter, Saffaroni,
Jaeobsen, Levy, Jeanlos, Scherikor and Pincus, 1951). In
this connection it has been found that whereas 17a-
hydroxylation of progesterone was not achieved with ad¬
renal glands of the steer, it was accomplished with
adrenal glands of the cow (Knox, Auerbach and Lin, 1956).
Werbin, Le Roy and Bergenstal (1955) injected a woman
with progesterone-4—C14 and obtained radioactive cryst¬




dione) and 3a-hydroxy-5p-androstan-17-one were isolated
also, but with very nrach lower specific activities than
the pregnanediol indicating that only a small proportion
of the progesterone was converted to these substances.
This provides in vivo evidence for the scheme of Hechter
and Pincus (1954-) and for the removal of the side-chain
of progesterone. It means also that besides the con¬
version of allopregnanes to androstones, discussed above,
pregnanes may be transformed to 5P-androstones (astio-
cholanes).
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1) Biochemical Reduction Products of Progesterone
Taylor (1954) obtained allopregnanedione and
allopregnanolone, but not pregnanediol, as metabolic
products after incubation of progesterone with rat
liver homogenate, The first metabolite was identified
tentatively after incubation of progesterone with 5,000£
and 25,000g supernatants (p, 56). The fact that preg¬
nanediol is not a metabolite was confirmed by the
present work, which showed that this steroid, if formed
at all, constituted less than of the metabolic
products (p. 108), This method could possibly be
applied to the determination of pregnanediol in the
presence of other tissue homogenates or cell fractions.
The solution obtained after addition of sulphuric acid
to the allopregnanediol fraction (p. 107) had a clear
yellow fluorescent appearance, typical of that given
by some steroids and quite unlike the brown colour pro¬
duced by the presence of impurities. The nature of
this material has not been determined yet, but it is
the author*s intention to investigate it further.
After incubation of progesterone with rabbit
liver homogenate Taylor (1955) isolated pregnen¬
olone, -hydroxy-5a-pregnan-20-one and pregnane¬
diol as well as the two allopregnane derivatives
obtained with rat liver homogenate, mentioned above,
Ungar (see Forchielli, Rosenkrantz and Dorfman,
1955) incubated pregnenolone with rat liver homog¬
enate and obtained 5£-pregnane-5a:20p-diol; since
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the former has been shown to be a metabolite of progest¬
erone (Dorfman et al.,1948) 5P-pregnane-3a:2Qp-diol may be
considered an in vitro product of progesterone. Davis
et al.(1956) observed the excretion of 5a-pregnane-
30:2Qci-diol in the urine of pregnant, but not non¬
pregnant, womenj when progesterone was administered to
pregnant women, Plotz et al.(1956) found increased
urinary excretion of 5a-pregnane-30:20a-diol in only
one case out of three, that in which 1 g. of progest¬
erone was administered orally. Thus 5a-pregnane-
3£3:20a-diol may be regarded tentatively as a progesterone
metabolite.
Tomlcins et al. (1954) using a purified 78,000g
supernatant from a rat liver homogenate (isselbacher
and Tomkins, 1954) identified only pregnane derivatives
after incubation with cortisone; these authors showed
also that their preparation caused the loss of absorp¬
tion at 240 mg. of progesterone. After incubation of
progesterone with 5,00Qg and 25,000g supernatants of
rat liver homogenate, a 5a-pregnane was tentatively
identified (p. 56). Taylor (1955) obtained both
pregnanes and 5a-pregnanes from the same enzyme prep¬
aration, a rabbit liver homogenate. Thus it would
appear that there are two enzymes in homogenate, one
catalysing 5a reduction and the other 5f3 reduction.
The former appears to be in the microsomes, while
the latter must be in the supernatant. In confirm¬
ation of this, Forehielli and Dorfman (see Dorfman,
FIGURE 8. METABOLISM OF II- OEOXYCORTISOL BY RAT LIVER PREPARATIONS.
CH-OH
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19551s) incubated 11-deoxycortisol with "both a residue
(microsomes) separable between 6,000^ and 78,000g from
a rat liver homogenate and the 78,000£ supernatant
(microsome-free), With the microsomes, only a 5<x-
pregnane was obtained and with the supernatant, only
pregnanesj incubation with the 6,000g_ supernatant
yielded 5c,~pregnanes only (Porchielli et al, , 1956).
The metabolism of 11-deoxycoriisol (Iliibener and Schmidt-
Thome, 1955j Porchielli et al,, 1955, 1956) is shown in
Pig, 8; one product not detected is bracketed and Gi9
derivatives are omitted,
Ungar, Dorfmsn, Stecher and Vignos (1951) admin¬
istered pregnanedione orally to a woman and isolated
pregnanediol from the urine; they also administered
GllQ-prernanedione orally to a man and obtained allo-
pregnanediol and 5a-pregnane-3|3:20a-diol from the
urine, While this is supporting evidence that the
two diones are intermediates in the reductive metab¬
olism of progesterone, it is not conclusive since the
amount of the Alois in the urines before administr¬
ation were not determined. However, from the work of
Tonkins et al. (1954) it would appear probable that, in
rat liver at least, the normal metabolic pathway for
the reduction of Ring A of progesterone is hydrogen-
ation of the double bond to give the two diones,
followed by reduction of the 5-keto group.
Liver tissue is capable of reducing the 20-keto
■Ibl—
group of some steroids without affecting Ring A.
Thus, Caspi et al# (1S56) incubated DOC and 11-deoxy-
cortisol with hog liver homogenate and isolated the
corresponding 2Ca-hydroxy derivatives# Hiibener et al#
(1955) incubated 11-deoxyeortisol with rat liver homog¬
enate and obtained also mainly the 20c.-hydroxy deriv¬
ative with a small amount of the 20f-hydroxy compound;
however, Forchielii et al.(1950) obtained only the
latter substance after Incubating 11-deoxycortisol
with a 6,QQ0g supernatant from rat liver homogenate.
Cortisol, incubated with rat liver microsomes again
yielded the 2Op-hydroxy derivative (Glenn et al#,1956)•
As yet, however, reduction of progesterone to a
20-hydroxy derivative by liver tissue has not been
reported, though reduction to the 20$-hydroxy compound
by corpus luteum homogenate has been accomplished
(Hayano et al., 1954),
J) Correlation of in vivo and in vitro Studies
One purpose of in vitro work is to attempt to
isolate one small part of the metabolism of the whole
organism and to carry out the reactions under cond¬
itions as near physiological as possible, consistent
with the Isolation of metabolic products. In so far
as iS vivo an<3- is vitro results agree, this has been
achieved successfully.
The rabbit has been shown to excrete pregnanediol
<*132»"
in the urine after injection of progesterone (Hoffman,
1942); this in vivo observation agrees with the in vitr<j>
finding of Taylor (1955) who obtained pregnanediol after
incubation of progesterone with rabbit liver homogenate,
Taylor (1954) did not find pregnanediol after incubation
of progesterone with rat liver homogenate and the pres¬
ent work confirms this (p. 107); it agrees also with
t
the finding that pregnanediol was not detected in the
urine of the rat after progesterone injection (p. 78),
Correlation between in vivo and in vitro results has
been found also with the studies on the inhibition of
steroid reduction by G-A and PGA discussed on p, 120,
However, one difference between in vivo and in vitro
studies is that intermediate metabolites, which might
be removed from the cell and carried away in the bleod
in vivo, remain in situ and may be metabolized further,
in vitro. Thus we may expect also some differences in
results, as is indeed the case. For example, cortico-
sterone (lip:21-dihydroxy-pregn-4-ene-3:20-dione) is
the main steroid found in adrenal vein blood of the rat
but Eisenstein (1956) showed that halved rat adrenals,
Incubated with ACTH (adrenocorticotrophic hormone),
produced 11a;21-dihydroxy-pregn-4—ene-3;20-diono,
For reference, a Table of sixteen possible re¬
duction products of progesterone has been included;
abbreviated references have been used to provide a
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the detection of the substance has not been reported
yet in the literature. Such compounds as 5:20-
dihydroxy-pregn-4-enes, 20-hydroxy-5a(or p) -pregnan-
3-ones and derivatives with oxygen functions in
positions other than 3 or 20, or a double bond other
than in position 4 have not been included. Where
applicable, those references have been given to studies
in which an attempt was made to demonstrate that the
steroid reported was a progesterone metabolite.
Otherwise, investigations on human pregnancy urine,
for in vivo work, and on rat liver, for in vitro work,
have been favoured.
K) Suggestions for Further Work
In view of the numerous metabolites of 11-deoxy-
cortisol (Fig. 8, facing p. 130), it is possible that
investigation of the metabolites of progesterone
obtained with rat liver homogenate or cell fractions
would repay further study. By means of partition
chromatography, one could separate progesterone from
its 20-hydroxy derivatives; their detection should be
relatively simple by talcing advantage of the strong
absorption at 240 mg. of ap-unsaturated ketonic steroids.
Any of the compounds listed in the Table opposite
could be used as substrates and their metabolites
investigated.
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Advantage could be taken of the experience gained
in this work to carry out an isolation study with human
liver; Reaven (1955) has shown that of3-unsaturated
ketonic steroids lose their absorption at 240 mp when
incubated with human liver slices. In an experiment
not reported here, the author obtained some destruction
of progesterone with an homogenate prepared from human
liver, obtained as long as 18 hr, after death.
L) Conclusion
It is apparent that the metabolism of progesterone
is a subject of considerable complexity end therefore
of great interest; in vitro studies and analyses of
blood, bile ana excreta of various species will all
contribute towards its elucidation. Only when progest¬
erone metabolism is fully understood, will it be possible







It has been shown that when rat liver homogenate
was separated into cell fractions, the major activity,
with regard to the destruction of progesterone,resided
in the 5,000£ supernatant# The nuclear and mitochond¬
rial fractions were inactive, but when combined they
exhibited some activity# When the 5,OOC5£ supernatant
was separated into its two components, the microsomal
fraction was still active but the supernatant required
the addition of TPNH. Citrate increased markedly the
activity of 5,00C)£ supernatant and of supernatant, and
it is possible that this tricarboxylic acid functions
by keeping TEN in the reduced state, since other workers
have shown that a purified supernatant is not active
in the presence of TEN, unless an enzyme system is
added to keep the TPN in the reduced state. Isocitrio
dehydrogenase catalyses the reduction of TEN by iso-
citrate and requires the presence of Mg++ or Mn++, the
latter being more effective# Addition of Mg++ and
Mn++ to a 5,000g supernatant showed that Mn++ was more
effective as a co-factor for progesterone metabolism;
further, addition of these metallic ions to a dlalysed
supernatant did not affect its activity# These
observations are consistent with the TPN-reducing role
of citrate, since dialysed supernatant contains no
citrate or isocitrate.
GA inhibited progesterone and DOG metabolism; this
136-
was not due to inhibition of TPN reduction since
addition of GA to a TPN-reducing system did not affect
the degree of reduction of TPN attained. Thus it may
"be concluded that GA inhibits the enzyme which reduces
o|3-unsaturated ketonic steroids. DGA inhibited
progesterone metabolism only to a small extent; since
the ketonic group is lacking in this compound, it may
be deduced that the ap-unsaturated ketonic group of GA
is necessary for its inhibitory activity. Confirmation
of this was obtained when it was found that methyl
vinyl ketone inhibited progesterone metabolism but did
not inhibit TPN reduction.
Progesterone was injected intraperitoneally into
male rats and the urine and faeces, and also the urine
of pregnant rats, were examined for possible progest¬
erone metabolites. Neither pregnanediol nor allopreg-
nanediol was detected in the urine, though the analyt¬
ical methods used would have detected amounts equival¬
ent to 0. G5$£ of the progesterone injected. By use
of 2:4-dinitrophenylhydrazine followed by alumina
chromatography, it was shown that allopregnanedione,
pregnanedione and aXLopregnanolone, if present at all
in male urine, constituted less than 0.3$ of the
progesterone injected. No progesterone metabolites
were obtained from the faeces, but coprostan-3p-ol was
isolated.
Hat liver, when subsequently homogenized and tested
-137-
for activity with regard to progesterone metabolism*
was found to be stable for 24 hr. at 0°, whereas liver
cooled to -20° for 24 hr# lost some activity; homogenats
stored at 0° lost activity* but 5,000£ supernatant did
not# A method was evolved for the determination of
pregnanediol in the presence of liver tissue; using this
method it was shown that after incubation of progest¬
erone with homogenate* pregnanediol, if formed at all,




Recently, v/ork has "been published in the literature
r/ith a bearing on aspects of progesterone metabolism
discussed in this thesis.
The probable pathway for reductive metabolism of
Sing A of progesterone, mentioned on p. 130, has been
supported by the work of Harold, Abraham and Chaikoff
(1956) who incubated cholest-4-en-3-one with rat liver
homogenate and obtained cholestan-3-one and cholestan-
3p-ol; incubation of cholestan-3-one yielded cholestan-
3£-ol.
Berliner and Wiest (1956) injected progesterone-^C14-*
intravenously into male rats and found that after 5 hr.
the highest concentration of radioactivity Y/as in the
liver, with the adrenals showing the next highest concen¬
tration; the concentration in the pituitary was not
determined* Intravenous injection into eviscerated
rats resulted in a concentration in the pituitary no
greater than that in the blood; these results may be
compared with those of Rlegel et al. (1950) described
on p. 3, bearing in mind that these investigators used
it
progesterone-21-C1* with intact animals.
This work was followed up by Wiest (1956) who injected
progesterone intravenously into eviscerated, adrenal-
ectomized female rats, killed the animals 2 hr. later,
extracted the carcasses and obtained 20c-hydroxy-pregn-
4-en-3-one; this is the first reported Instance of this
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compound having been obtained by methods other than
synthesis. Although, on chemical grounds, it seems
probable that this steroid is a progesterone metabolite,
this conclusion would have been strengthened if eviscer¬
ated, adrenalectomized female rats had been injected
with the progesterone solvent and their carcasses
examined.
This work demonstrated that it is possible to separ¬
ate 20a-hydroxy-pregn-4-en-3-one and progesterone (see
p. 133), since progesterone was recovered unchanged.
It confirms also that extrahepatic tissues can metabolise
progesterone (see p. 4). It is pointed out in this
paper that progesterone metabolites in the normal rat
seem to be different from those in the human, thus




Terms, Abbreviations and Trivial Names used in this
Thesis~
Throughout this Thesis, the practice has "been
followed in general of giving the full description at













DGA: 11-desoxoglycyrrhetinie acid (3p-hydroxy-olean-12-en-30-oic ac
Dihydrocortisone: 17a:21-dihydroxy-5p-pregnane-3:11:20-trione
DNP: 2: 4-clini trophenylhydrazone
DOC: 11-aeoxycorticosterone (21-hydroxy-pregn-4-ene-3:20-dione
DPN: diphosphopyridine nucleotide
DPNH: reduced diphosphopyridine nucleotide
GA: glycyrrhetinic acid (3p-hydroxy-ll-oxo-olean-12-en-30-oic acid)
M. S#E»: Measuring & Scientific Equipment, Ltd,









Supernatant: supernatant fluid; where this term Is used






TPNH: reduced triphosphopyridine nucleotide
Tris: 2-amino-2-(hydroxy-methyl)-propane-l: 3-diol
Versene: ethylene diamine tetra-acetic acid
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APPEHDIX IV
Purification of Organic Solvents
In general, the methods described by Weissberger
and Proskauer (1935) were used. The fractionating
column used was packed with Rasehig rings and had
dimensions of 40 x 5.5 cm,; final distillations were
carried out in all-glass apparatus using a calcium
chloride tube when solvents were required anhydrous.
Usually an electric heating mantle was used for
distillation flasks; solvents were stored in brown
bottles in a dark cupboard.
Acetone: Acetone, B.P, , the product of T. & II, Smith,
Ltd., was refluxed for 2 hr. with potassium permanganate
(10 g,/l, ) and NaOH (4 g./l, )• It was then distilled,
refluxed with freshly roasted potassium carbonate
(50 g./l») and distilled again under anhydrous
conditions.
Benzene: National Coal Board Benzole Ho, 1 was
distilled, the fraction boiling at 70-82° being
collected; this was washed five times with water and
twice with concentrated HaSO*, being shaken period¬
ically with the latter during 24 hr. It was then
washed with water till the washings were neutral,
dried over CaCls and distilled.
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Chloroform; Chloroform, B.P. , the product of T. & H.
Smith, Ltd., was washed four times with water, dried
over CaCl2 and distilled. The fraction "boiling at
59*63° was collected and redistilled, the first 50 ml.
of distillate being rejected. This solvent was
prepared freshly as required.
Diethyl Ether; Ether, A.R., the product of J. P. Mac-
Parian & Co., was dried over sodium wire and
distilled under anhydrous conditions.
Ethanol; Absolute re-rectified alcohol, the product
of the Distillers Co., Ltd., was refluxed with NaOH
* J .
(4 g»/l.) for 8 hr. and distilled twice under anhydrous
conditions.
Hexane: n-Hexane, obtained from Carless, Capel,
Leonard & Co., was allowed to stand in a large sep¬
arating funnel with three batches of concentrated
HgSCXfc (100 ml./l.), with occasional shaking, for 12 hr.
After washing with 2N-NaOH (100 ml./l.) and then with
water until the washings were neutral, it was dried
over CaCl3 and distilled, the first 50 ml. of the
distillate being rejected.
Methanol: I.C.I. methanol was treated in the same way
as ethanol.
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Petroleum Ethert Petroleum ether (b.p, range 40-60°),
manufactured ty W. & J. George & Becker, Ltd,, was
distilled, the fraction "boiling at 40-60° "being
collected.
Pyridine: Commercial pyridine was dried over freshly-
roasted BaO, filtered,and distilled under anhydrous
conditions, the fraction "boiling at 118-117° "being
collected and stored over a few lumps of BaO,
Toluene: 'Caterex* "brand toluene (Petrochemicals,




Numerical Details of Figures
1. The reduction of TPH by 25,0G0g supernatant and by
dialysed supernatant
Time In min. Optical Density at 340 mu.
















2. The oxidation of TPNH by dialysed 25.000^ supernatant
Time in min. Optical Density at 340 mp,.
TENH + dialysed TFNH + water
supernatant
0*5 0. 340 0.438
1.0 0. 322 0.438



















3. Metabolism of progesterone with time "by dialysed
25»000g supernatant








5. TPH reduction "by concurrent oxidation of glucose-6-
phosphate in the absence and! in the presence of &A
Time in min. Optical Density at 340 mp.
OA absent OA present
1 0. 329 0.184
2 0. 382 0.284
3 0.406 0.368
4 0. 418 0.407
5 0.427 0. 425
6 0. 431 0.433
7 0.436 0.438
8 0.439 0.440
9 0.441 0. 442
10 0.444 0. 444
20 0.458 0.457
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tion by concurrent oxidation of glueose-G-
"
in the absence "and"in'"the presence of
ketone









5 0. 424 0.412
6 0. 434 0.427
7 0.437 0. 433





7.Alumina chromatography of urinary dinitrophenylhydrazones
Optical Density at 570 my..
Fraction
"UuEBer C M P ad a
1 0.422 0.269 0.350 0.800 0.936
2 2.816 3. 360 2.700 2.620 2.352
3 0.800 1. 205 1.030 0.180 0. 204
4 0. 354 0. 551 0. 346 0. 301 0.246
5 0.274 0.457 0.253 0.224 0.189
6 0.185 0.251 0.178 0.178 0.122
7 0.556 0.782 0.425 1.450 0.700
8 0.808 0.864 0.738 1.550 0.858
9 0.726 0.860 1. 099 0.819 0. 571
10 0. 608 0.821 1.200 0.560 0.429
11 0.459 0.649 0.881 0.478 0.474
12 0. 336 0.552 0.536 0.431 0. 695
13 0.252 0.364 0. 328 0.370 0.500
14 0.186 0.268 0.223 0.294 0. 325
15 0.139 0.196 0.154 0.226 0.24-4
16 0.269 0.342 0.233 0. 425 0.416
17 0.802 1.150 0.698 0. 800 0. 804
18 0.953 1.330 0.978 0.739 0.712
19 0.739 1. 130 0.729 0. 548 0. 4-69
20 0.981 1.510 0.980 0.700 0.622
21 0.778 1.4-10 0.769 0.719 0.669
22 0.829 1.400 0.809 0.878 0.851
23 0. 678 1.400 0.700 0.701 0.729
24 0.812 1.110 0.818 0.670 0.679
25 0.639 1.140 0.629 0.441 0.485
26 0.619 1.480 0.576 0.675 0.629
27 0. 640 1.700 0.621 0.729 0. 681
28 1.700 1.970 1.690 1.700 1.650
C » Control Ketones
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